<!DOCTYPE html> <html lang=en class=js style><!--
 Page saved with SingleFile 
 url: https://link.springer.com/article/10.1186/s13063-019-3306-7 
 saved date: Wed Aug 10 2022 11:46:02 GMT+0200 (Central European Summer Time)
--><meta charset=utf-8>
<meta http-equiv=X-UA-Compatible content="IE=edge">
<meta name=viewport content="width=device-width, initial-scale=1">
<meta name=applicable-device content=pc,mobile>
<meta name=access content=Yes>
<meta name=citation_abstract content="Psychotherapy for borderline personality disorder is often lengthy and resource-intensive. However, the current length of outpatient treatments is arbitrary and based on trials that never tested if the treatment intensity could be reduced. As a result, there is insufficient evidence to inform the decision between short-term and long-term psychotherapy for borderline personality disorder. Mentalization-based therapy is one treatment option for borderline personality disorder and consists traditionally of an 18-month treatment program. This trial is an investigator-initiated single-center randomized clinical superiority trial of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. Participants will be recruited from the Outpatient Clinic for Personality Disorders at Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark. Participants will be included if they meet a minimum of four DSM-V criteria for borderline personality disorder. Participants will be assessed before randomization, and at 8, 16, and 24 months after randomization. The primary outcome is severity of borderline symptomatology assessed with the Zanarini Rating Scale for borderline personality disorder. Secondary outcomes include self-harm incidents, functional impairment (Work and Social Adjustment Scale, Global Assessment of Functioning) and quality of life (Short-Form Health Survey 36). Severity of psychiatric symptoms (Symptom Checklist 90-R) will be included as an exploratory outcome. Measures of personality functioning, attachment, borderline symptoms, group alliance, and mentalization skills will be included to explore potential predictors and mechanisms of change. This trial will provide evidence of the beneficial and harmful effects of short-term compared to long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. ClinicalTrials.gov, 
                  NCT03677037
                  
                . Registered on September 19, 2018.">
<meta name=journal_id content=13063>
<meta name=dc.title content="Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial">
<meta name=dc.source content="Trials 2019 20:1">
<meta name=dc.format content=text/html>
<meta name=dc.publisher content="BioMed Central">
<meta name=dc.date content=2019-04-05>
<meta name=dc.type content=OriginalPaper>
<meta name=dc.language content=En>
<meta name=dc.copyright content="2019 The Author(s).">
<meta name=dc.rights content="2019 The Author(s).">
<meta name=dc.rightsAgent content=reprints@biomedcentral.com>
<meta name=dc.description content="Psychotherapy for borderline personality disorder is often lengthy and resource-intensive. However, the current length of outpatient treatments is arbitrary and based on trials that never tested if the treatment intensity could be reduced. As a result, there is insufficient evidence to inform the decision between short-term and long-term psychotherapy for borderline personality disorder. Mentalization-based therapy is one treatment option for borderline personality disorder and consists traditionally of an 18-month treatment program. This trial is an investigator-initiated single-center randomized clinical superiority trial of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. Participants will be recruited from the Outpatient Clinic for Personality Disorders at Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark. Participants will be included if they meet a minimum of four DSM-V criteria for borderline personality disorder. Participants will be assessed before randomization, and at 8, 16, and 24 months after randomization. The primary outcome is severity of borderline symptomatology assessed with the Zanarini Rating Scale for borderline personality disorder. Secondary outcomes include self-harm incidents, functional impairment (Work and Social Adjustment Scale, Global Assessment of Functioning) and quality of life (Short-Form Health Survey 36). Severity of psychiatric symptoms (Symptom Checklist 90-R) will be included as an exploratory outcome. Measures of personality functioning, attachment, borderline symptoms, group alliance, and mentalization skills will be included to explore potential predictors and mechanisms of change. This trial will provide evidence of the beneficial and harmful effects of short-term compared to long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. ClinicalTrials.gov, NCT03677037 . Registered on September 19, 2018.">
<meta name=prism.issn content=1745-6215>
<meta name=prism.publicationName content=Trials>
<meta name=prism.publicationDate content=2019-04-05>
<meta name=prism.volume content=20>
<meta name=prism.number content=1>
<meta name=prism.section content=OriginalPaper>
<meta name=prism.startingPage content=1>
<meta name=prism.endingPage content=10>
<meta name=prism.copyright content="2019 The Author(s).">
<meta name=prism.rightsAgent content=reprints@biomedcentral.com>
<meta name=prism.url content=https://link.springer.com/articles/10.1186/s13063-019-3306-7>
<meta name=prism.doi content=doi:10.1186/s13063-019-3306-7>
<meta name=citation_pdf_url content=https://link.springer.com/track/pdf/10.1186/s13063-019-3306-7>
<meta name=citation_fulltext_html_url content=https://link.springer.com/articles/10.1186/s13063-019-3306-7>
<meta name=citation_journal_title content=Trials>
<meta name=citation_journal_abbrev content=Trials>
<meta name=citation_publisher content="BioMed Central">
<meta name=citation_issn content=1745-6215>
<meta name=citation_title content="Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial">
<meta name=citation_volume content=20>
<meta name=citation_issue content=1>
<meta name=citation_publication_date content=2019/12>
<meta name=citation_online_date content=2019/04/05>
<meta name=citation_firstpage content=1>
<meta name=citation_lastpage content=10>
<meta name=citation_article_type content="Study protocol">
<meta name=citation_fulltext_world_readable content>
<meta name=citation_language content=en>
<meta name=dc.identifier content=doi:10.1186/s13063-019-3306-7>
<meta name=DOI content=10.1186/s13063-019-3306-7>
<meta name=size content=149726>
<meta name=citation_doi content=10.1186/s13063-019-3306-7>
<meta name=citation_springer_api_url content="http://api.springer.com/xmldata/jats?q=doi:10.1186/s13063-019-3306-7&amp;api_key=">
<meta name=description content="Psychotherapy for borderline personality disorder is often lengthy and resource-intensive. However, the current length of outpatient treatments is arbitrary and based on trials that never tested if the treatment intensity could be reduced. As a result, there is insufficient evidence to inform the decision between short-term and long-term psychotherapy for borderline personality disorder. Mentalization-based therapy is one treatment option for borderline personality disorder and consists traditionally of an 18-month treatment program. This trial is an investigator-initiated single-center randomized clinical superiority trial of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. Participants will be recruited from the Outpatient Clinic for Personality Disorders at Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark. Participants will be included if they meet a minimum of four DSM-V criteria for borderline personality disorder. Participants will be assessed before randomization, and at 8, 16, and 24 months after randomization. The primary outcome is severity of borderline symptomatology assessed with the Zanarini Rating Scale for borderline personality disorder. Secondary outcomes include self-harm incidents, functional impairment (Work and Social Adjustment Scale, Global Assessment of Functioning) and quality of life (Short-Form Health Survey 36). Severity of psychiatric symptoms (Symptom Checklist 90-R) will be included as an exploratory outcome. Measures of personality functioning, attachment, borderline symptoms, group alliance, and mentalization skills will be included to explore potential predictors and mechanisms of change. This trial will provide evidence of the beneficial and harmful effects of short-term compared to long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. ClinicalTrials.gov, NCT03677037 . Registered on September 19, 2018.">
<meta name=dc.creator content="Juul, Sophie">
<meta name=dc.creator content="Lunn, Susanne">
<meta name=dc.creator content="Poulsen, Stig">
<meta name=dc.creator content="Sørensen, Per">
<meta name=dc.creator content="Salimi, Mehrak">
<meta name=dc.creator content="Jakobsen, Janus Christian">
<meta name=dc.creator content="Bateman, Anthony">
<meta name=dc.creator content="Simonsen, Sebastian">
<meta name=dc.subject content="Medicine/Public Health, general">
<meta name=dc.subject content="Biomedicine, general">
<meta name=dc.subject content="Statistics for Life Sciences, Medicine, Health Sciences">
<meta name=citation_reference content="American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington: American Psychiatric Pub; 2013.">
<meta name=citation_reference content="citation_inbook_title=Prevalence, Sociodemographics, and Functional Impairment, in Textbook of personality disorders; citation_publication_date=2014; citation_pages=109-131; citation_id=CR2; citation_author=J Togersen; citation_publisher=American Psychiatric Publishing">
<meta name=citation_reference content="citation_journal_title=Compr Psychiatry; citation_title=Patterns of covariation of DSM-IV personality disorders in a mixed psychiatric sample; citation_author=A Fossati; citation_volume=41; citation_issue=3; citation_publication_date=2000; citation_pages=206-215; citation_doi=10.1016/S0010-440X(00)90049-X; citation_id=CR3">
<meta name=citation_reference content="citation_journal_title=Am J Psychiatr; citation_title=The prevalence of DSM-IV personality disorders in psychiatric outpatients; citation_author=M Zimmerman, L Rothschild, I Chelminski; citation_volume=162; citation_issue=10; citation_publication_date=2005; citation_pages=1911-1918; citation_doi=10.1176/appi.ajp.162.10.1911; citation_id=CR4">
<meta name=citation_reference content="citation_journal_title=Compr Psychiatry; citation_title=Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure; citation_author=MI Korzekwa; citation_volume=49; citation_issue=4; citation_publication_date=2008; citation_pages=380-386; citation_doi=10.1016/j.comppsych.2008.01.007; citation_id=CR5">
<meta name=citation_reference content="citation_journal_title=Am J Psychiatr; citation_title=Borderline Personality Disorder in Clinical Practice; citation_author=CZ Conklin, D Westen; citation_volume=162; citation_publication_date=2005; citation_pages=867-875; citation_doi=10.1176/appi.ajp.162.5.867; citation_id=CR6">
<meta name=citation_reference content="citation_journal_title=Am J Psychiatr; citation_title=Axis I comorbidity of borderline personality disorder; citation_author=MC Zanarini; citation_volume=155; citation_publication_date=1998; citation_pages=1733-1739; citation_doi=10.1176/ajp.155.12.1733; citation_id=CR7">
<meta name=citation_reference content="citation_journal_title=Clin Psychol Rev; citation_title=Borderline personality disorder and substance use disorders A review and integration; citation_author=TJ Trull; citation_volume=20; citation_issue=2; citation_publication_date=2000; citation_pages=235-253; citation_doi=10.1016/S0272-7358(99)00028-8; citation_id=CR8">
<meta name=citation_reference content="citation_journal_title=Compr Psychiatry; citation_title=Axis II comorbidity in borderline personality disorder is influenced by sex, age, and clinical severity; citation_author=J Barrachina; citation_volume=52; citation_issue=6; citation_publication_date=2011; citation_pages=725-730; citation_doi=10.1016/j.comppsych.2010.11.009; citation_id=CR9">
<meta name=citation_reference content="citation_journal_title=Br J Psychiatry; citation_title=Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials; citation_author=K Lieb; citation_volume=196; citation_issue=1; citation_publication_date=2010; citation_pages=4-12; citation_doi=10.1192/bjp.bp.108.062984; citation_id=CR10">
<meta name=citation_reference content="citation_journal_title=Lancet; citation_title=Treatment of personality disorder; citation_author=AW Bateman, J Gunderson, R Mulder; citation_volume=385; citation_issue=9969; citation_publication_date=2015; citation_pages=735-743; citation_doi=10.1016/S0140-6736(14)61394-5; citation_id=CR11">
<meta name=citation_reference content="citation_journal_title=JAMA Psychiatry; citation_title=Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis; citation_author=IA Cristea; citation_volume=74; citation_issue=4; citation_publication_date=2017; citation_pages=319-328; citation_doi=10.1001/jamapsychiatry.2016.4287; citation_id=CR12">
<meta name=citation_reference content="citation_journal_title=Am J Psychiatr; citation_title=Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder; citation_author=A Bateman, P Fonagy; citation_volume=166; citation_issue=12; citation_publication_date=2009; citation_pages=1355-1364; citation_doi=10.1176/appi.ajp.2009.09040539; citation_id=CR13">
<meta name=citation_reference content="Bateman A, Fonagy P. Mentalization-based treatment for personality disorders: a practical guide. Oxford: Oxford University Press; 2016.">
<meta name=citation_reference content="Karterud S. Mentalization-Based Group Therapy (MBT-G): A theoretical, clinical, and research manual. Oxford: OUP Oxford; 2015.">
<meta name=citation_reference content="Vogt KS, Norman P. Is mentalization-based therapy effective in treating the symptoms of borderline personality disorder? A systematic review. Psychol Psychother. 2018. 
                  https://doi.org/10.1111/papt.12194
                  
                
                        ">
<meta name=citation_reference content="citation_journal_title=Annu Rev Clin Psychol; citation_title=Mediators and mechanisms of change in psychotherapy research; citation_author=AE Kazdin; citation_volume=3; citation_publication_date=2007; citation_pages=1-27; citation_doi=10.1146/annurev.clinpsy.3.022806.091432; citation_id=CR17">
<meta name=citation_reference content="citation_journal_title=Psychol Psychother; citation_title=Changing from a traditional psychodynamic treatment programme to mentalization-based treatment for patients with borderline personality disorder--does it make a difference?; citation_author=EH Kvarstein; citation_volume=88; citation_issue=1; citation_publication_date=2015; citation_pages=71-86; citation_doi=10.1111/papt.12036; citation_id=CR18">
<meta name=citation_reference content="citation_journal_title=J Personal Disord; citation_title=Treatment outcome of 18-month, day hospital mentalization-based treatment (MBT) in patients with severe borderline personality disorder in the netherlands; citation_author=D Bales; citation_volume=26; citation_issue=4; citation_publication_date=2012; citation_pages=568-582; citation_doi=10.1521/pedi.2012.26.4.568; citation_id=CR19">
<meta name=citation_reference content="citation_journal_title=Acta Psychiatr Scand; citation_title=Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial; citation_author=CR Jorgensen; citation_volume=127; citation_issue=4; citation_publication_date=2013; citation_pages=305-317; citation_doi=10.1111/j.1600-0447.2012.01923.x; citation_id=CR20">
<meta name=citation_reference content="citation_journal_title=Am J Psychiatr; citation_title=Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial; citation_author=A Bateman, P Fonagy; citation_volume=156; citation_issue=10; citation_publication_date=1999; citation_pages=1563-1569; citation_doi=10.1176/ajp.156.10.1563; citation_id=CR21">
<meta name=citation_reference content="Laurenssen EM, Luyten P, Kikkert MJ, Westra D, Peen J, Soons MB, Dekker JJ. Day hospital mentalization-based treatment v. specialist treatment as usual in patients with borderline personality disorder: randomized controlled trial. Psychol Med. 2018;48(15):2522–29">
<meta name=citation_reference content="citation_journal_title=Am J Psychiatr; citation_title=8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual; citation_author=A Bateman, P Fonagy; citation_volume=165; citation_issue=5; citation_publication_date=2008; citation_pages=631-638; citation_doi=10.1176/appi.ajp.2007.07040636; citation_id=CR23">
<meta name=citation_reference content="citation_journal_title=Psychol Med; citation_title=Randomized controlled trial and uncontrolled 9-month follow-up of an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder; citation_author=KL Gratz, MT Tull, R Levy; citation_volume=44; citation_issue=10; citation_publication_date=2014; citation_pages=2099-2112; citation_doi=10.1017/S0033291713002134; citation_id=CR24">
<meta name=citation_reference content="citation_journal_title=Am J Psychiatr; citation_title=Systems Training for Emotional Predictability and Problem Solving (STEPPS) for Outpatients With Borderline Personality Disorder: A Randomized Controlled Trial and 1-Year Follow-Up; citation_author=N Blum, D St. John, B Pfohl, S Stuart, B McCormick, J Allen, S Arndt, DW Black; citation_volume=165; citation_publication_date=2008; citation_pages=468-478; citation_doi=10.1176/appi.ajp.2007.07071079; citation_id=CR25">
<meta name=citation_reference content="citation_journal_title=J Nerv Ment Dis; citation_title=A randomized controlled trial of a Dutch version of systems training for emotional predictability and problem solving for borderline personality disorder; citation_author=EH Bos, EB Wel, MT Appelo, MJ Verbraak; citation_volume=198; citation_issue=4; citation_publication_date=2010; citation_pages=299-304; citation_doi=10.1097/NMD.0b013e3181d619cf; citation_id=CR26">
<meta name=citation_reference content="citation_journal_title=Acta Psychiatr Scand; citation_title=A randomized trial of brief dialectical behaviour therapy skills training in suicidal patients suffering from borderline disorder; citation_author=SF McMain; citation_volume=135; citation_issue=2; citation_publication_date=2017; citation_pages=138-148; citation_doi=10.1111/acps.12664; citation_id=CR27">
<meta name=citation_reference content="citation_journal_title=J Clin Psychol; citation_title=Advances in the Treatment of Borderline Personality Disorder: An Introduction to the Special Issue; citation_author=SF McMain; citation_volume=71; citation_issue=8; citation_publication_date=2015; citation_pages=741-746; citation_doi=10.1002/jclp.22201; citation_id=CR28">
<meta name=citation_reference content="citation_journal_title=Psychol Med; citation_title=Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up; citation_author=P Knekt; citation_volume=38; citation_issue=5; citation_publication_date=2008; citation_pages=689-703; citation_doi=10.1017/S003329170700164X; citation_id=CR29">
<meta name=citation_reference content="citation_journal_title=Br J Psychiatry; citation_title=Comparison of short- and long-term dynamic group psychotherapy: randomised clinical trial; citation_author=S Lorentzen; citation_volume=203; citation_issue=3; citation_publication_date=2013; citation_pages=280-287; citation_doi=10.1192/bjp.bp.112.113688; citation_id=CR30">
<meta name=citation_reference content="citation_journal_title=Ann Intern Med; citation_title=Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration; citation_author=I Boutron; citation_volume=148; citation_issue=4; citation_publication_date=2008; citation_pages=295-309; citation_doi=10.7326/0003-4819-148-4-200802190-00008; citation_id=CR31">
<meta name=citation_reference content="citation_journal_title=BMC Med Res Methodol; citation_title=The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials; citation_author=D Moher, KF Schulz, DG Altman; citation_volume=1; citation_publication_date=2001; citation_pages=2; citation_doi=10.1186/1471-2288-1-2; citation_id=CR32">
<meta name=citation_reference content="citation_journal_title=Ann Intern Med; citation_title=SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials; citation_author=A Chan; citation_volume=158; citation_publication_date=2013; citation_pages=200-207; citation_doi=10.7326/0003-4819-158-3-201302050-00583; citation_id=CR33">
<meta name=citation_reference content="Simonsen S, Heinskou T, Sørensen P, Folke S, Lau ME. Personality disorders: patient characteristics and level of outpatient treatment service. Nord J Psychiatry. 2017;71(5):325–31.">
<meta name=citation_reference content="citation_journal_title=Compr Psychiatry; citation_title=Evidence for a single latent class of Diagnostic and Statistical Manual of Mental Disorders borderline personality pathology; citation_author=A Clifton, PA Pilkonis; citation_volume=48; citation_issue=1; citation_publication_date=2007; citation_pages=70-78; citation_doi=10.1016/j.comppsych.2006.07.002; citation_id=CR35">
<meta name=citation_reference content="citation_journal_title=Lancet; citation_title=Classification, assessment, prevalence, and effect of personality disorder; citation_author=P Tyrer, GM Reed, MJ Crawford; citation_volume=385; citation_issue=9969; citation_publication_date=2015; citation_pages=717-726; citation_doi=10.1016/S0140-6736(14)61995-4; citation_id=CR36">
<meta name=citation_reference content="citation_journal_title=Trials; citation_title=Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial; citation_author=E Beck; citation_volume=17; citation_issue=1; citation_publication_date=2016; citation_pages=314; citation_doi=10.1186/s13063-016-1431-0; citation_id=CR37">
<meta name=citation_reference content="citation_journal_title=J Personal Disord; citation_title=Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology; citation_author=null Zanarini; citation_volume=17; citation_issue=3; citation_publication_date=2003; citation_pages=233-242; citation_doi=10.1521/pedi.17.3.233.22147; citation_id=CR38">
<meta name=citation_reference content="National Insitute for Health and Care Excellence (NICE). Borderline Personality Disorder: the NICE Guideline on Treatment and Management. Br Psychol Soc R Coll Psychiatrists. 2009.">
<meta name=citation_reference content="Karterud S, Bateman A. Manual for mentaliseringsbasert psykoedukativ gruppeterapi (MBT-I). Oslo: Gyldendal akademisk; 2011.">
<meta name=citation_reference content="citation_title=National klinisk retningslinje for behandling af emotionel ustabil personlighedsstruktur, borderline type; citation_publication_date=2015; citation_id=CR41">
<meta name=citation_reference content="citation_journal_title=Eur Psychiatry; citation_title=The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI; citation_author=Y Lecrubier; citation_volume=12; citation_publication_date=1997; citation_pages=224-231; citation_doi=10.1016/S0924-9338(97)83296-8; citation_id=CR42">
<meta name=citation_reference content="citation_journal_title=J Personal Disord; citation_title=The Structured Clinical Interview for DSM-II-R Personality Disorders (SCID-II). Part II: Multi-site test-retest reliability study; citation_author=MB First; citation_volume=9; citation_issue=2; citation_publication_date=1995; citation_pages=92-104; citation_doi=10.1521/pedi.1995.9.2.92; citation_id=CR43">
<meta name=citation_reference content="citation_journal_title=Clin Psychol Psychother; citation_title=Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II); citation_author=J Lobbestael, M Leurgans, A Arntz; citation_volume=18; citation_issue=1; citation_publication_date=2011; citation_pages=75-79; citation_doi=10.1002/cpp.693; citation_id=CR44">
<meta name=citation_reference content="citation_journal_title=Psychol Assess; citation_title=Guidelines, Criteria, an Rules of Thumb for Evaluating Normed and Standardized Assessment Instruments in Psychology; citation_author=DV Cicchetti; citation_volume=6; citation_issue=4; citation_publication_date=1994; citation_pages=284-290; citation_doi=10.1037/1040-3590.6.4.284; citation_id=CR45">
<meta name=citation_reference content="citation_journal_title=Personal Ment Health; citation_title=The Work and Social Adjustment Scale: Psychometric properties and validity among males and females, and outpatients with and without personality disorders; citation_author=G Pedersen, EH Kvarstein, T Wilberg; citation_volume=11; citation_issue=4; citation_publication_date=2017; citation_pages=215-228; citation_doi=10.1002/pmh.1382; citation_id=CR46">
<meta name=citation_reference content="Miles HH, Barrabee EL, Finesinger JE. Evaluation of psychotherapy: with a follow up study of 62 cases of anxiety neurosis. Psychosom Med. 1951 Mar-Apr;13(2):83-105.">
<meta name=citation_reference content="citation_journal_title=Med Care; citation_title=The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection; citation_author=JE Ware, CD Sherbourne; citation_volume=30; citation_issue=6; citation_publication_date=1992; citation_pages=473-483; citation_doi=10.1097/00005650-199206000-00002; citation_id=CR48">
<meta name=citation_reference content="citation_journal_title=Br J Psychiatry; citation_title=Reliability and Validity of the Global Assessment of Functioning (GAF); citation_author=SH Jones; citation_volume=166; citation_publication_date=1995; citation_pages=654-659; citation_doi=10.1192/bjp.166.5.654; citation_id=CR49">
<meta name=citation_reference content="citation_journal_title=J Clin Psychol; citation_title=Confirmation of the dimensional structure of the SCL-90: a study in construct validation; citation_author=LR Derogatis, PA Cleary; citation_volume=33; citation_issue=4; citation_publication_date=1977; citation_pages=981-989; citation_doi=10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0; citation_id=CR50">
<meta name=citation_reference content="citation_journal_title=Personal Disord Theory Res Treat; citation_title=Development and Preliminary Psychometric Evaluation of a Brief Self-Report Questionnaire for the Assessment of the DSM–5 Level of Personality Functioning Scale: The LPFS Brief Form (LPFS-BF); citation_author=J Hutsebaut, D Feensta, J Kamphuis; citation_volume=7; citation_issue=2; citation_publication_date=2016; citation_pages=192-194; citation_doi=10.1037/per0000159; citation_id=CR51">
<meta name=citation_reference content="citation_journal_title=J Pers Soc Psychol; citation_title=Attachment Styles Among Young Adults: A Test of a Four-Category Model; citation_author=K Bartholomew, LM Horowitz; citation_volume=61; citation_issue=2; citation_publication_date=1991; citation_pages=226-244; citation_doi=10.1037/0022-3514.61.2.226; citation_id=CR52">
<meta name=citation_reference content="citation_journal_title=Personal Ment Health; citation_title=Development of the self-report version of the Zanarini Rating Scale for Borderline Personality Disorder; citation_author=null Zanarini; citation_volume=9; citation_issue=4; citation_publication_date=2015; citation_pages=243-249; citation_doi=10.1002/pmh.1302; citation_id=CR53">
<meta name=citation_reference content="citation_journal_title=Psychother Res; citation_title=The Group Questionnaire: a clinical and empirically derived measure of group relationship; citation_author=J Krogel; citation_volume=23; citation_issue=3; citation_publication_date=2013; citation_pages=344-354; citation_doi=10.1080/10503307.2012.729868; citation_id=CR54">
<meta name=citation_reference content="citation_journal_title=Psychother Res; citation_title=Is a self-rated instrument appropriate to assess mentalization in patients with mental disorders? Development and first validation of the Mentalization Questionnaire (MZQ); citation_author=M Hausberg, H Schulz, T Piegler, C Happach, M Klöpper, A Brütt; citation_volume=22; citation_issue=6; citation_publication_date=2012; citation_pages=699-709; citation_doi=10.1080/10503307.2012.709325; citation_id=CR55">
<meta name=citation_reference content="citation_journal_title=Control Clin Trials; citation_title=Blinding during data analysis and writing of manuscripts; citation_author=PC Gotzsche; citation_volume=17; citation_issue=4; citation_publication_date=1996; citation_pages=285-290; citation_doi=10.1016/0197-2456(95)00263-4; citation_id=CR56">
<meta name=citation_reference content="citation_journal_title=J Clin Epidemiol; citation_title=Blinded interpretation of study results can feasibly and effectively diminish interpretation bias; citation_author=TL Jarvinen; citation_volume=67; citation_issue=7; citation_publication_date=2014; citation_pages=769-772; citation_doi=10.1016/j.jclinepi.2013.11.011; citation_id=CR57">
<meta name=citation_reference content="citation_journal_title=Psychother Psychosom; citation_title=Effectiveness and cost-effectiveness of dialectical behaviour therapy for self-harming patients with personality disorder: a pragmatic randomised controlled trial; citation_author=S Priebe; citation_volume=81; citation_issue=6; citation_publication_date=2012; citation_pages=356-365; citation_doi=10.1159/000338897; citation_id=CR58">
<meta name=citation_reference content="citation_journal_title=BMC Med Res Methodol; citation_title=The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials; citation_author=JC Jakobsen; citation_volume=14; citation_publication_date=2014; citation_pages=34; citation_doi=10.1186/1471-2288-14-34; citation_id=CR59">
<meta name=citation_reference content="citation_journal_title=BMC Med Res Methodol; citation_title=When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts; citation_author=JC Jakobsen; citation_volume=17; citation_issue=1; citation_publication_date=2017; citation_pages=162; citation_doi=10.1186/s12874-017-0442-1; citation_id=CR60">
<meta name=citation_reference content="Englev E, Petersen KP. ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives. Dan Med J. 2003;165(16):1659–62.">
<meta name=citation_author content="Juul, Sophie">
<meta name=citation_author_institution content="Stolpegaard Psychotherapy Centre, Mental Health Services, Gentofte, Denmark">
<meta name=citation_author_institution content="Department of Psychology, University of Copenhagen, Copenhagen, Denmark">
<meta name=citation_author content="Lunn, Susanne">
<meta name=citation_author_institution content="Department of Psychology, University of Copenhagen, Copenhagen, Denmark">
<meta name=citation_author content="Poulsen, Stig">
<meta name=citation_author_institution content="Department of Psychology, University of Copenhagen, Copenhagen, Denmark">
<meta name=citation_author content="Sørensen, Per">
<meta name=citation_author_institution content="Stolpegaard Psychotherapy Centre, Mental Health Services, Gentofte, Denmark">
<meta name=citation_author content="Salimi, Mehrak">
<meta name=citation_author_institution content="Stolpegaard Psychotherapy Centre, Mental Health Services, Gentofte, Denmark">
<meta name=citation_author content="Jakobsen, Janus Christian">
<meta name=citation_author_institution content="Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark">
<meta name=citation_author content="Bateman, Anthony">
<meta name=citation_author_institution content="St. Anns Hospital, London, England">
<meta name=citation_author content="Simonsen, Sebastian">
<meta name=citation_author_institution content="Stolpegaard Psychotherapy Centre, Mental Health Services, Gentofte, Denmark">
<meta property=og:url content=https://link.springer.com/article/10.1186/s13063-019-3306-7>
<meta property=og:type content=article>
<meta property=og:site_name content=SpringerLink>
<meta property=og:title content="Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial - Trials">
<meta property=og:description content="Background Psychotherapy for borderline personality disorder is often lengthy and resource-intensive. However, the current length of outpatient treatments is arbitrary and based on trials that never tested if the treatment intensity could be reduced. As a result, there is insufficient evidence to inform the decision between short-term and long-term psychotherapy for borderline personality disorder. Mentalization-based therapy is one treatment option for borderline personality disorder and consists traditionally of an 18-month treatment program. Methods/design This trial is an investigator-initiated single-center randomized clinical superiority trial of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. Participants will be recruited from the Outpatient Clinic for Personality Disorders at Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark. Participants will be included if they meet a minimum of four DSM-V criteria for borderline personality disorder. Participants will be assessed before randomization, and at 8, 16, and 24 months after randomization. The primary outcome is severity of borderline symptomatology assessed with the Zanarini Rating Scale for borderline personality disorder. Secondary outcomes include self-harm incidents, functional impairment (Work and Social Adjustment Scale, Global Assessment of Functioning) and quality of life (Short-Form Health Survey 36). Severity of psychiatric symptoms (Symptom Checklist 90-R) will be included as an exploratory outcome. Measures of personality functioning, attachment, borderline symptoms, group alliance, and mentalization skills will be included to explore potential predictors and mechanisms of change. Discussion This trial will provide evidence of the beneficial and harmful effects of short-term compared to long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. Trial registration ClinicalTrials.gov, NCT03677037 . Registered on September 19, 2018.">
<meta property=og:image content=https://media.springernature.com/w200/springer-static/cover/journal/13063.jpg>
<title>Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial | SpringerLink</title>
<link rel=icon sizes=48x48 type=image/png href="data:image/png;base64,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">
<style>@media only print,only all and (prefers-color-scheme:no-preference),only all and (prefers-color-scheme:light),only all and (prefers-color-scheme:dark){a{text-decoration:underline;text-decoration-skip-ink:auto}html{text-size-adjust:100%;-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}body{background:#fcfcfc;font-size:1.125rem;line-height:1.5;max-width:100%;min-height:100%}article,aside,header,main,nav,section{display:block}h1{margin:.67em 0}a{background-color:transparent;color:#004b83;overflow-wrap:break-word;word-break:break-word}b{font-weight:bolder}img{border:0;height:auto;max-width:100%;vertical-align:middle}svg:not(:root){overflow:hidden}button{font-size:100%}button{overflow:visible}button{text-transform:none}[type=submit],button,html [type=button]{-webkit-appearance:button}button{border-radius:0;cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:inherit}h1,h2{font-family:Georgia,Palatino,serif}h1{font-style:normal}h2{font-style:normal;margin-bottom:1em}*{box-sizing:inherit}body,button,div,form{margin:0;padding:0}p{padding:0}p{margin:0}h1,h2,ul{margin-top:0}p{margin-bottom:1.5em;overflow-wrap:break-word;word-break:break-word}p:last-child{margin-bottom:0}p:empty{display:none}.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#f7fbfe;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}.c-skip-link:link{color:#004b83}.c-status-message{align-items:center;box-sizing:border-box;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;position:relative;width:100%}.c-status-message :last-child{margin-bottom:0}.c-status-message--boxed{background-color:#fff;border:1px solid #ccc;border-radius:2px;line-height:1.4;padding:16px}.c-status-message__icon{fill:currentcolor;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-header{background-color:#fff;border-bottom:4px solid #00285a;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;padding:16px 0}.c-header__container,.c-header__menu{align-items:center;display:flex;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu{gap:2em 2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:inherit}@supports not (gap:2em){.c-header__item{margin-left:24px}}.c-header__container{justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}@supports not (gap:2em){.c-header__brand{margin-right:32px}}.c-header__brand a{display:block;text-decoration:none}.c-header__link{color:inherit;text-decoration:none}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li{display:inline;padding-right:0}.c-article-author-list__item svg{margin-left:4px}@media only screen and (max-width:539px){.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list svg{margin:1px 4px 0 0}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#069;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fcfcfc;border-bottom:1px solid #fcfcfc;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-article-section__figure-description{font-size:1rem}.c-article-section__figure-description>*{margin-bottom:0}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{flex:1 1 0%;padding:13px 24px!important}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-article-extras .c-pdf-container{flex-wrap:wrap;width:100%}.c-article-extras .c-pdf-container .c-pdf-download{width:100%}.u-button--primary svg{fill:currentcolor}.u-button{align-items:center;border-radius:2px;cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s}.u-button--primary{background-color:#33629d;background-image:linear-gradient(#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5);color:#fff}.u-button--full-width{display:flex;width:100%}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-display-flex{display:flex;width:100%}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-button-reset{background-color:transparent;border:0;padding:0}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-position-relative{position:relative}.u-mt-16{margin-top:16px}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mb-8{margin-bottom:8px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-float-left{float:left}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-text-sm{font-size:1rem}.hide{display:none;visibility:hidden}.visually-hidden{clip:rect(1px,1px,1px,1px);height:1px;position:absolute!important;width:1px}@media only screen and (max-width:30em){.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-section__figure-description{font-family:Georgia,Palatino,serif}.c-article-section__content p{line-height:1.8}.c-reading-companion__sections-list{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-section__title,.c-article-title{font-weight:400}.c-header__cart-icon{margin-right:12px}.c-header__navigation{display:flex}}</style>
<style media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">@-webkit-keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@-webkit-keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}@keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}a{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}html{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;height:100%;overflow-y:scroll;font-size:100%;box-sizing:border-box;color:#333;line-height:1.6180339888;-moz-osx-font-smoothing:auto;-webkit-font-smoothing:subpixel-antialiased}body{line-height:1.5;max-width:100%;min-height:100%;background:#fcfcfc;font-size:1.125rem}article,aside,figcaption,figure,footer,header,main,nav,section{display:block}h1{margin:.67em 0}figure{margin:0}a{background-color:transparent;color:#004b83;word-wrap:break-word;overflow-wrap:break-word;word-break:break-word;text-decoration-thickness:.0625rem;text-underline-offset:.08em}a:active,a:hover{outline-width:0}abbr[title]{border-bottom:none;-webkit-text-decoration:underline dotted}b{font-weight:bolder}dfn{font-style:italic}img{border:0;max-width:100%;height:auto;vertical-align:middle}svg:not(:root){overflow:hidden}button{font-size:100%}button{overflow:visible}button{text-transform:none}[type=submit],button,html [type=button]{-webkit-appearance:button}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}a:focus,a:hover{text-decoration:underline}button{cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;border-radius:0;line-height:inherit}b:focus,dd:focus,div:focus,dl:focus,dt:focus,em:focus,h1:focus,h2:focus,h3:focus,h4:focus,h5:focus,i:focus,li:focus,ol:focus,p:focus,span:focus,strong:focus,ul:focus{outline:0}h1,h2{font-family:Georgia,Palatino,serif}h1{font-style:normal}.u-h3{font-style:normal;margin-bottom:1em;font-family:Georgia,Palatino,serif;font-weight:400}.u-h3{font-size:min(max(1.25rem,3vw),1.5rem)}h2,h3{font-style:normal;margin-bottom:1em}.u-h3 a,abbr[title]{text-decoration:none}.c-article-editorial-summary__container .c-article-editorial-summary__article-title a.active,.c-article-editorial-summary__container .c-article-editorial-summary__article-title a.hover,.c-article-editorial-summary__container .c-article-editorial-summary__article-title a:active,.c-article-editorial-summary__container .c-article-editorial-summary__article-title a:hover,.c-card__title a.active,.c-card__title a.hover,.c-card__title a:active,.c-card__title a:hover,.c-reading-companion__figure-title a.active,.c-reading-companion__figure-title a.hover,.c-reading-companion__figure-title a:active,.c-reading-companion__figure-title a:hover,.u-h3 a.active,.u-h3 a.hover,.u-h3 a:active,.u-h3 a:hover,.u-h4 a.active,.u-h4 a.hover,.u-h4 a:active,.u-h4 a:hover,.u-h5 a.active,.u-h5 a.hover,.u-h5 a:active,.u-h5 a:hover,h3 a.active,h3 a.hover,h3 a:active,h3 a:hover,h4 a.active,h4 a.hover,h4 a:active,h4 a:hover,h5 a.active,h5 a.hover,h5 a:active,h5 a:hover,h6 a.active,h6 a.hover,h6 a:active,h6 a:hover{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}h4{margin-bottom:1em}[contenteditable]:focus,[tabindex="0"]:focus,button:focus,input:focus,select:focus,textarea:focus{outline:4px solid #fc0}button:disabled:focus,input:disabled:focus,select:disabled:focus,textarea:disabled:focus{outline:0}*,:after,:before{box-sizing:inherit}body,button,div,dt,form{margin:0;padding:0}dd,dl,p{padding:0}a.visited,a:visited{color:#a345c9}a.hover,a:hover{color:#0061a9}a.active,a:active{color:#003b84;text-decoration:none}a.focus,a:focus{outline:4px solid #fc0}a>img{vertical-align:middle}dl,p{margin:0}h1,h2,h3,h4,ol,ul{margin-top:0}ol:not([class]),ul:not([class]){padding-left:.9em}dd{margin:0}p{margin-bottom:1.5em;word-wrap:break-word;overflow-wrap:break-word;word-break:break-word}.c-card__summary>p:last-child,p:last-child{margin-bottom:0}p:empty{display:none}a:hover{text-decoration:underline;text-decoration-thickness:.3875rem;text-underline-offset:.08em}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0;aspect-ratio:var(--card--image-aspect-ratio, 16/9)}}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{width:100%;height:100%;-o-object-fit:cover;object-fit:cover}}.c-skip-link{background:#f7fbfe;color:#004b83;font-size:.875rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;text-align:center;padding:8px;position:absolute;inset:0;bottom:auto;z-index:9999;transform:translateY(-100%)}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out}}.c-skip-link:active,.c-skip-link:hover,.c-skip-link:link,.c-skip-link:visited{color:#004b83}.c-skip-link:focus{transform:translateY(0)}.c-status-message{display:flex;align-items:center;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;position:relative;width:100%;box-sizing:border-box}.c-status-message :last-child{margin-bottom:0}.c-status-message--boxed{background-color:#fff;border-radius:2px;border:1px solid #ccc;line-height:1.4;padding:16px}.c-status-message__icon{fill:currentColor;transform:translate(0,0);display:inline-block;vertical-align:text-top;width:1.5em;height:1.5em;flex:0 0 auto;margin-right:8px}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1.125rem;background-color:#fff;padding:16px 0;border-bottom:4px solid #00285a}.c-header__container,.c-header__menu{display:flex;align-items:center;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu,.c-header__nav-menu{gap:2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:inherit}@supports not (gap:2em){.c-header__item{margin-left:24px}}@supports not (gap:2em){.c-header__nav .c-header__item{margin-left:0;margin-right:24px}}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px;justify-content:space-between}@supports not (gap:2em){.c-header__brand{margin-right:32px}}.c-header__brand a{text-decoration:none;display:block}.c-header__link{text-decoration:none;color:inherit}.c-header__link.active,.c-header__link.hover,.c-header__link:active,.c-header__link:hover{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.c-header__link:hover,.c-header__link:visited{color:inherit}.c-user-metadata{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:.75rem;color:#666;line-height:1.4;padding-top:24px}.c-user-metadata__item{margin-top:0;margin-bottom:4px}.c-article-editorial-summary__container .c-article-editorial-summary__content p:last-child,.c-user-metadata__item:last-child{margin-bottom:0}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:40px}.c-article-identifiers{list-style:none;font-size:1rem;line-height:1.3;display:flex;flex-wrap:wrap;color:#6f6f6f;padding:0;margin:0 0 8px}.c-article-identifiers__item{border-right:1px solid #6f6f6f;margin-right:8px;padding-right:8px;list-style:none}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0;border-right:0}.c-article-identifiers__open{color:#b74616}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{font-size:1rem;display:inline;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li{display:inline;padding-right:0}.c-article-author-list__item svg{margin-left:4px}@media only screen and (max-width:539px){.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list svg{margin:1px 4px 0 0}.c-article-metrics-bar{display:flex;flex-wrap:wrap;line-height:1.3;font-size:1rem}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-weight:400;font-style:normal;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-author-affiliation__list,.c-article-references{list-style:none;padding:0}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;padding-bottom:8px;margin:0}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{padding-top:8px;margin-bottom:40px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__pill-button{padding:8px 16px 8px 20px;background-color:#fff;border:4px solid #bcd2dc;border-radius:20px;font-size:.875rem;line-height:1.4;font-weight:700;margin-bottom:10px;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;text-decoration:none;display:inline-flex;align-items:center}.c-article__pill-button:hover{background-color:#069;color:#fff;text-decoration:none}.c-article__pill-button:focus{outline:0;box-shadow:0 0 0 3px #fece3e;text-decoration:none}.c-article__pill-button:active,.c-article__pill-button:hover{box-shadow:0 0 0 0}.c-article__pill-button svg{height:.8em;margin-left:2px}.c-article__sub-heading{font-size:1.125rem;font-weight:400;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-style:normal;line-height:1.3;color:#222;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-article__sub-heading--small{font-size:1.125rem;font-weight:700}.c-article-references__item{display:flex;flex-wrap:wrap;border-bottom:1px solid #d5d5d5;padding-bottom:16px;margin-bottom:16px}.c-article-references__item::before{content:attr(data-counter);font-size:1.5rem;line-height:1.4;text-align:right}@media only screen and (max-width:1023px){.c-article-references__item::before{font-size:1.125rem;line-height:inherit}}.c-article-references__item>p.c-article-references__text{flex:1;padding-left:8px}.c-article-references__text{margin-bottom:8px}.c-article-references__links{display:flex;flex-basis:100%;justify-content:flex-end;flex-wrap:wrap;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;font-weight:700;margin:0;padding:0;list-style:none}.c-article-references__links>a{padding-left:8px}.c-article-references__links>a:first-child{padding-left:0}.c-article-references__download{text-align:right}.c-article-references__download>a{font-size:1rem;font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-references__download svg,.c-bibliographic-information__download-citation svg{margin-left:4px}.c-article-author-affiliation__address{color:inherit;font-weight:700;margin:0}.c-article-author-affiliation__authors-list{padding:0;list-style:none;margin-bottom:16px;margin-top:0}.c-article-supplementary__item{margin-bottom:24px;position:relative}.c-article-supplementary__description>*{margin-bottom:0}.c-article-supplementary__title{margin:0 0 8px;line-height:1.5}.c-article-subject-list{font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;list-style:none;display:flex;flex-wrap:wrap;padding:0;margin:0 0 24px}.c-article-subject-list__subject{background-color:#e1e1e1;border-radius:20px;padding:4px 10px;font-weight:700;margin-right:15px;margin-bottom:16px;flex:0 1 auto}.c-bibliographic-information{display:flex;padding-top:8px}@media only screen and (max-width:1023px){.c-bibliographic-information{padding-top:0;display:block}}.c-bibliographic-information__value{font-size:1rem;display:block}.c-bibliographic-information__column:first-child{width:81px;flex:0 0 81px}@media only screen and (max-width:1023px){.c-bibliographic-information__column:first-child{width:100%}}.c-bibliographic-information__column:last-child{flex:1}.c-bibliographic-information__column--border{border-right:1px solid #d5d5d5;margin-right:24px}@media only screen and (max-width:1023px){.c-bibliographic-information__column--border{border-bottom:1px solid #d5d5d5;padding-bottom:8px;margin-bottom:8px;border-right:0;margin-right:0}}.c-bibliographic-information__list{list-style:none;margin:0;padding:0;display:flex;justify-content:flex-start;flex-wrap:wrap}.c-bibliographic-information__list-item{flex:0 0 33%;box-sizing:border-box;padding-right:8px;margin-bottom:16px;font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}@media only screen and (max-width:1023px){.c-bibliographic-information__list-item{flex:0 0 100%}}.c-bibliographic-information__list-item p{margin-bottom:0}.c-bibliographic-information__list-item:last-child{padding-right:0}.c-bibliographic-information__list-item--doi{flex:0 0 100%}.c-bibliographic-information__citation,.c-bibliographic-information__download-citation{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;margin-bottom:8px}.c-bibliographic-information__download-citation{margin-bottom:24px}.c-article-share-box{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-share-box__description{font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:8px}.c-article-share-box__additional-info{color:#626262;font-size:.813rem;margin-bottom:24px}.c-article-share-box__button{background:#fff;border:1px solid #069;box-sizing:content-box;color:#069;font-size:1rem;line-height:1.5;margin-bottom:8px;padding:8px 20px;text-align:center}@supports ((-webkit-backdrop-filter:blur(10px)) or (backdrop-filter:blur(10px))){.c-context-bar--sticky:after{background:linear-gradient(to top,rgba(255,255,255,.75) 50%,#fff);-webkit-backdrop-filter:blur(10px);backdrop-filter:blur(10px)}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{overflow-x:hidden;overflow-y:auto;margin:0;min-height:200px}.c-reading-companion__tabs{font-size:1rem;list-style:none;display:flex;flex-direction:row;flex-wrap:nowrap;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{color:#069;border:solid #d5d5d5;border-width:1px 1px 1px 0;background-color:#eee;padding:8px 8px 8px 15px;text-align:left;font-size:1rem;width:100%}.c-reading-companion__tab:focus{text-decoration:none;outline-offset:-4px}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{color:#222;background-color:#fcfcfc;border-bottom:1px solid #fcfcfc;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;padding:8px 0 8px 16px;line-height:1.5;overflow:hidden;white-space:nowrap;text-overflow:ellipsis}.c-reading-companion__section-item--active a{white-space:normal;border-left:4px solid #d5d5d5;padding-left:12px;color:#222}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-article-section__figure{border:2px solid #d5d5d5;padding:20px 10px;max-width:100%;margin-bottom:24px;clear:both}.c-article-section__figure-caption{margin-bottom:8px;display:block;word-break:break-word}.c-article-section__figure-content{margin-bottom:16px}.c-article-section__figure-item{max-width:100%}.c-article-section__figure-link{max-width:100%;display:block;margin:0 0 16px;padding:0}.c-article-section__figure-item img{display:block;margin:0 auto}.c-article-section__figure-description{font-size:1rem}.c-article-section__figure-description>*{margin-bottom:0}.c-article-table{border:2px solid #d5d5d5;clear:both;padding:20px 10px;margin-bottom:24px}.c-article-table__figcaption{line-height:1.4;margin-bottom:16px;word-break:break-word}.app-footer-edition-list li.selected a{font-weight:700}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{flex:1;padding:13px 24px!important}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-article-extras .c-pdf-container{width:100%;flex-wrap:wrap}.c-article-extras .c-pdf-container .c-pdf-download{width:100%}@supports (display:grid) and (grid-auto-rows:auto){.c-article-metrics__legend ul{display:grid;grid-column-gap:8px;grid-auto-rows:auto;grid-template-columns:repeat(auto-fill,minmax(120px,1fr))}@media only screen and (min-width:540px){.c-article-metrics__legend ul{padding-left:16px;grid-template-columns:repeat(2,50%)}}@media only screen and (min-width:1024px){.c-article-metrics__legend ul{grid-template-columns:repeat(3,33%)}}.c-article-metrics__legend ul li{font-size:.875rem}}.app-footer{background-color:#fcfcfc}.app-footer,.app-footer-edition-list a,.app-footer-edition-list a:active,.app-footer-edition-list a:hover,.app-footer-edition-list a:visited,.app-footer__copyright a,.app-footer__copyright a:active,.app-footer__copyright a:hover,.app-footer__copyright a:visited,.app-footer__nav a,.app-footer__nav a:active,.app-footer__nav a:hover,.app-footer__nav a:visited{color:#626262}.app-footer__container{margin:0 auto;max-width:1280px;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:.875rem;padding:16px}.app-footer__aside-wrapper{border:1px solid #eee;border-left:0;border-right:0}.app-footer__strapline{font-size:1.0625rem;display:block;margin-top:0;margin-bottom:16px}@media only screen and (min-width:768px){.app-footer__strapline{display:inline-block;margin-bottom:0}.app-footer__edition{float:right;margin-bottom:0}}.app-footer-edition-list{list-style:none;margin:0;padding:0}.app-footer-edition-list li{display:inline-block}.app-footer-edition-list li:first-child{border-right:1px solid #eee;margin-right:.5em;padding-right:.5em}.app-footer__nav{list-style:none;padding:0;margin:0 0 16px}.app-footer__nav li{display:inline-block;border-right:1px solid #eee;margin-right:.5em;padding-right:.5em}.app-footer__nav li:last-child{border-right:none;padding-right:0}.app-footer__parent-logo{display:inline-block;margin-bottom:16px}.app-footer__copyright{font-size:.75rem;margin:0}.u-button--primary svg{fill:currentColor}.u-button{align-items:center;cursor:pointer;margin:0;position:relative;text-decoration:none;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;line-height:1.3;padding:8px;transition:.25s ease,color .25s ease,border-color .25s ease;border-radius:2px}.u-button,.u-button:visited{color:#004b83}.u-button:hover{border:1px solid #666;text-decoration:none}.u-button:focus{border:1px solid #666;text-decoration:none}.u-button:focus,.u-button:hover{color:#fff;background-color:#666;background-image:none}.u-button--primary{color:#fff;background-color:#33629d;background-image:linear-gradient(to bottom,#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5)}.u-button--primary:visited{color:#fff}.u-button--primary:hover{border:1px solid #0061a9}.u-button--primary:focus{border:1px solid #0061a9}.u-button--primary:focus,.u-button--primary:hover{color:#fff;background-color:#0061a9;background-image:none}.u-button--disabled,.u-button:disabled{color:#333;background-color:transparent;background-image:none;border:1px solid #ccc;opacity:.67;cursor:default}.u-button--disabled svg,.u-button:disabled svg{fill:currentColor}.u-button--disabled:visited,.u-button:disabled:visited{color:#333}.u-button--disabled:hover,.u-button:disabled:hover{border:1px solid #ccc;text-decoration:none}.u-button--disabled:focus,.u-button:disabled:focus{border:1px solid #ccc;text-decoration:none}.u-button--disabled:focus,.u-button--disabled:hover,.u-button:disabled:focus,.u-button:disabled:hover{color:#333;background-color:transparent;background-image:none}.u-button--full-width{display:flex;width:100%}.u-clearfix::after,.u-clearfix::before{content:"";display:table}.u-clearfix::after{clear:both}.u-display-inline{display:inline}.u-display-flex{display:flex;width:100%}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.u-icon{fill:currentColor;transform:translate(0,0);display:inline-block;vertical-align:text-top;width:1em;height:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-bold{font-weight:700}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-position-relative{position:relative}.u-mt-16{margin-top:16px}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mb-8{margin-bottom:8px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-pr-16{padding-right:16px}.u-float-left{float:left}.app-footer__nav a{text-decoration:underline}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.app-footer__nav a:hover,.u-interface-link{text-decoration:none}.u-text-sm{font-size:1rem}.u-text-right{text-align:right}.hide{display:none;visibility:hidden}.visually-hidden{width:1px;height:1px;position:absolute!important;clip:rect(1px,1px,1px,1px)}@media only screen and (max-width:30em){.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-section__figure-description{font-family:Georgia,Palatino,serif}.app-footer-edition-list a:hover,.app-footer__copyright a:hover{text-decoration:inherit}.c-article-section__content p{line-height:1.8}.c-bibliographic-information,.c-reading-companion__sections-list{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-bibliographic-information__list-item{line-height:1.4}.c-article-section__title,.c-article-title{font-weight:400}.c-header__cart-icon{margin-right:12px}.c-header__navigation{display:flex}</style>
<link rel=canonical href=https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3306-7>
<script type=application/ld+json>{"mainEntity":{"headline":"Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial","description":"Psychotherapy for borderline personality disorder is often lengthy and resource-intensive. However, the current length of outpatient treatments is arbitrary and based on trials that never tested if the treatment intensity could be reduced. As a result, there is insufficient evidence to inform the decision between short-term and long-term psychotherapy for borderline personality disorder. Mentalization-based therapy is one treatment option for borderline personality disorder and consists traditionally of an 18-month treatment program. This trial is an investigator-initiated single-center randomized clinical superiority trial of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. Participants will be recruited from the Outpatient Clinic for Personality Disorders at Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark. Participants will be included if they meet a minimum of four DSM-V criteria for borderline personality disorder. Participants will be assessed before randomization, and at 8, 16, and 24 months after randomization. The primary outcome is severity of borderline symptomatology assessed with the Zanarini Rating Scale for borderline personality disorder. Secondary outcomes include self-harm incidents, functional impairment (Work and Social Adjustment Scale, Global Assessment of Functioning) and quality of life (Short-Form Health Survey 36). Severity of psychiatric symptoms (Symptom Checklist 90-R) will be included as an exploratory outcome. Measures of personality functioning, attachment, borderline symptoms, group alliance, and mentalization skills will be included to explore potential predictors and mechanisms of change. This trial will provide evidence of the beneficial and harmful effects of short-term compared to long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. ClinicalTrials.gov, \n                  NCT03677037\n                  \n                . Registered on September 19, 2018.","datePublished":"2019-04-05","dateModified":"2019-04-05","pageStart":"1","pageEnd":"10","license":"http://creativecommons.org/publicdomain/zero/1.0/","sameAs":"https://doi.org/10.1186/s13063-019-3306-7","keywords":"Medicine/Public Health,general,Biomedicine,Statistics for Life Sciences,Medicine,Health Sciences","image":"https://static-content.springer.com/image/art%3A10.1186%2Fs13063-019-3306-7/MediaObjects/13063_2019_3306_Fig1_HTML.png","isPartOf":{"name":"Trials","issn":["1745-6215"],"volumeNumber":"20","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"BioMed Central","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Juul, Sophie","url":"http://orcid.org/0000-0002-6171-2904","affiliation":[{"name":"Mental Health Services","address":{"name":"Stolpegaard Psychotherapy Centre, Mental Health Services, Gentofte, Denmark","@type":"PostalAddress"},"@type":"Organization"},{"name":"University of Copenhagen","address":{"name":"Department of Psychology, University of Copenhagen, Copenhagen, Denmark","@type":"PostalAddress"},"@type":"Organization"}],"email":"sophie.juul@regionh.dk","@type":"Person"},{"name":"Lunn, Susanne","affiliation":[{"name":"University of Copenhagen","address":{"name":"Department of Psychology, University of Copenhagen, Copenhagen, Denmark","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Poulsen, Stig","affiliation":[{"name":"University of Copenhagen","address":{"name":"Department of Psychology, University of Copenhagen, Copenhagen, Denmark","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Sørensen, Per","affiliation":[{"name":"Mental Health Services","address":{"name":"Stolpegaard Psychotherapy Centre, Mental Health Services, Gentofte, Denmark","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Salimi, Mehrak","affiliation":[{"name":"Mental Health Services","address":{"name":"Stolpegaard Psychotherapy Centre, Mental Health Services, Gentofte, Denmark","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Jakobsen, Janus Christian","affiliation":[{"name":"Copenhagen University Hospital","address":{"name":"Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Bateman, Anthony","affiliation":[{"name":"St. Anns Hospital","address":{"name":"St. Anns Hospital, London, England","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Simonsen, Sebastian","affiliation":[{"name":"Mental Health Services","address":{"name":"Stolpegaard Psychotherapy Centre, Mental Health Services, Gentofte, Denmark","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>
<style>#MathJax_Message{position:fixed;left:1em;bottom:1.5em;background-color:#E6E6E6;border:1px solid #959595;margin:0px;padding:2px 8px;z-index:102;color:black;font-size:80%;width:auto;white-space:nowrap}.sf-hidden{display:none!important}</style><meta http-equiv=content-security-policy content="default-src 'none'; font-src 'self' data:; img-src 'self' data:; style-src 'unsafe-inline'; media-src 'self' data:; script-src 'unsafe-inline' data:;"></head>
<body class=shared-article-renderer><div id=MathJax_Message style=display:none></div>
 
 
 
 
 
 <noscript data-test=gtm-body>
                <iframe src="https://collect.springer.com/ns.html?id=GTM-MRVXSHQ"
                height="0" width="0" style="display:none;visibility:hidden"></iframe>
            </noscript>
 
 
 
 <div class=u-vh-full>
 <a class=c-skip-link href=#main-content>Skip to main content</a>
 
 <div class="u-hide u-show-following-ad sf-hidden"></div>
 <aside class="c-ad c-ad--728x90 sf-hidden" data-test=springer-doubleclick-ad>
 </aside>
<div class=u-position-relative>
 <header class="c-header u-mb-24" data-test=publisher-header>
 
 <div class=c-header__container>
 <div class=c-header__brand>
 
 <a id=logo class=u-display-block href=https://link.springer.com/ title="Go to homepage" data-test=springerlink-logo>
 <picture>
 
 <img src="data:image/svg+xml;base64,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" alt=SpringerLink width=148 height=30 data-test=header-academic srcset sizes>
 </picture>
 
 
 </a>
 </div>
 <div class=c-header__navigation>
 
 
 <button type=button class="c-header__link u-button-reset u-mr-24" data-expander data-expander-target=#popup-search data-expander-autofocus=firstTabbable data-test=header-search-button aria-haspopup=true aria-expanded=false>
 <span class="u-display-flex u-align-items-center">
 <span class=u-text-sm>Search</span>
 <svg class="u-icon u-flex-static u-ml-8" aria-hidden=true focusable=false>
 <use xlink:href=#global-icon-search></use>
 </svg>
 </span>
 </button>
 <div class=c-header__cart-icon>
 <div id=ecommerce-header-cart-icon-link class="c-header__item ecommerce-cart" style=display:inline-block;margin-right:10px>
 <form action=https://order.springer.com/public/precheckout method=post><button class=c-header__link type=submit style=appearance:none;border:none;background:none;color:inherit>
 <svg aria-hidden=true focusable=false height=18 viewBox="0 0 18 18" width=18 style=vertical-align:text-bottom xmlns=http://www.w3.org/2000/svg><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z" fill=#333></path>
 </svg><span class="u-screenreader-only visually-hidden">Go to cart</span></button>
 </form>
</div>
 </div>
 <nav>
 <ul class=c-header__menu>
 
 
 <li class=c-header__item>
 <a data-test=login-link class=c-header__link href="https://link.springer.com/signup-login?previousUrl=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1186%2Fs13063-019-3306-7" data-track=click data-track-category=header data-track-action="login header" data-track-label=link>Log in</a>
 </li>
 
 
 </ul>
 </nav>
 
 
 </div>
 </div>
 </header>
 
 <div id=popup-search class="c-popup-search u-mb-16 js-header-search u-js-hide sf-hidden" hidden>
 
 </div>
 
</div>
 
 <div class="u-container u-mt-32 u-mb-32 u-clearfix" id=main-content data-component=article-container>
 <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
 
 
 <div class="c-context-bar u-hide sf-hidden" data-test=context-bar data-context-bar aria-hidden=true>
 
 </div>
 
 
 <div class="c-pdf-button__container u-hide-at-lg js-context-bar-sticky-point-mobile sf-hidden">
 
 
 </div>
 
 <div class="c-article-collection__container sf-hidden">
 
 
 </div>
 <article lang=en>
 <div class=c-article-header>
 <header>
 <ul class=c-article-identifiers data-test=article-identifier>
 
 
 <li class=c-article-identifiers__item data-test=article-category>Study protocol</li>
 
 
 <li class=c-article-identifiers__item>
 <span class=c-article-identifiers__open data-test=open-access>Open Access</span>
 </li>
 
 
 <li class=c-article-identifiers__item><a href=#article-info data-track=click data-track-action="publication date" data-track-label=link>Published: <time datetime=2019-04-05>05 April 2019</time></a></li>
 </ul>
 
 <h1 class=c-article-title data-test=article-title data-article-title>Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial</h1>
 <ul class="c-article-author-list js-etal-collapsed js-no-scroll" data-etal=25 data-etal-small=3 data-test=authors-list data-component-authors-activator=authors-list><li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Sophie-Juul aria-label="Read more about Sophie Juul" data-author-popup=auth-Sophie-Juul data-corresp-id=c1>Sophie Juul<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-email></use></svg></a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden">,</sup>, <li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Susanne-Lunn aria-label="Read more about Susanne Lunn" data-author-popup=auth-Susanne-Lunn>Susanne Lunn</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Stig-Poulsen aria-label="Read more about Stig Poulsen" data-author-popup=auth-Stig-Poulsen>Stig Poulsen</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Per-S_rensen aria-label="Read more about Per Sørensen" data-author-popup=auth-Per-S_rensen>Per Sørensen</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Mehrak-Salimi aria-label="Read more about Mehrak Salimi" data-author-popup=auth-Mehrak-Salimi>Mehrak Salimi</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Janus_Christian-Jakobsen aria-label="Read more about Janus Christian Jakobsen" data-author-popup=auth-Janus_Christian-Jakobsen>Janus Christian Jakobsen</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__show-more u-js-hide js-small-screen-show-inline sf-hidden" aria-label="Show all 8 authors for this article" title="Show all 8 authors for this article">…<li class="c-article-author-list__item js-smaller-author-etal"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Anthony-Bateman aria-label="Read more about Anthony Bateman" data-author-popup=auth-Anthony-Bateman>Anthony Bateman</a><sup class="u-js-hide sf-hidden"></sup> &amp; <li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Sebastian-Simonsen aria-label="Read more about Sebastian Simonsen" data-author-popup=auth-Sebastian-Simonsen>Sebastian Simonsen</a><sup class="u-js-hide sf-hidden"></sup>&nbsp;</ul><button aria-expanded=false class="c-button-author-list js-etal-show-more u-js-hide js-small-screen-show-inline sf-hidden"><svg aria-hidden=true width=16 height=16 focusable=false class=u-icon><use href=#icon-plus></use></svg></button>
 <p class=c-article-info-details data-container-section=info>
 
 <a data-test=journal-link href=https://link.springer.com/journal/13063><i data-test=journal-title>Trials</i></a>
 <b data-test=journal-volume><span class=u-visually-hidden>volume</span>&nbsp;20</b>, Article&nbsp;number:&nbsp;<span data-test=article-number>196</span> (<span data-test=article-publication-year>2019</span>)
 <a href=#citeas class="c-article-info-details__cite-as u-hide-print" data-track=click data-track-action="cite this article" data-track-label=link>Cite this article</a>
 </p>
 
 
 <div data-test=article-metrics>
 <div id=altmetric-container>
 <div class="c-article-metrics-bar__wrapper u-clear-both">
 <ul class="c-article-metrics-bar u-list-reset">
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>5843 <span class=c-article-metrics-bar__label>Accesses</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>11 <span class=c-article-metrics-bar__label>Citations</span></p>
 </li>
 
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>1 <span class=c-article-metrics-bar__label>Altmetric</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__details><a href=https://link.springer.com/article/10.1186%2Fs13063-019-3306-7/metrics data-track=click data-track-action="view metrics" data-track-label=link rel=nofollow>Metrics <span class=u-visually-hidden>details</span></a></p>
 </li>
 </ul>
 </div>
</div>
 </div>
 
 
 <div class="u-mb-8 c-status-message c-status-message--boxed c-status-message--info">
 <span class=c-status-message__icon>
 <svg class=u-icon width=18 height=18 aria-hidden=true focusable=false>
 <use xlink:href=#icon-info></use>
 </svg>
 </span>
 
 
 <p>An <a href=https://link.springer.com/article/10.1186/s13063-021-05450-y class=relation-link data-track=click data-track-action="view linked article" data-track-label=link>Update</a> to this article was published on 28 July 2021</p>
 
 
 </div>
 
 
 
 </header>
 </div>
 <div data-article-body=true data-track-component="article body" class=c-article-body>
 <section aria-labelledby=Abs1 data-title=Abstract lang=en><div class=c-article-section id=Abs1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Abs1>Abstract</h2><div class=c-article-section__content id=Abs1-content><h3 class=c-article__sub-heading data-test=abstract-sub-heading>Background</h3><p>Psychotherapy for borderline personality disorder is often lengthy and resource-intensive. However, the current length of outpatient treatments is arbitrary and based on trials that never tested if the treatment intensity could be reduced. As a result, there is insufficient evidence to inform the decision between short-term and long-term psychotherapy for borderline personality disorder. Mentalization-based therapy is one treatment option for borderline personality disorder and consists traditionally of an 18-month treatment program.<h3 class=c-article__sub-heading data-test=abstract-sub-heading>Methods/design</h3><p>This trial is an investigator-initiated single-center randomized clinical superiority trial of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. Participants will be recruited from the Outpatient Clinic for Personality Disorders at Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark. Participants will be included if they meet a minimum of four DSM-V criteria for borderline personality disorder. Participants will be assessed before randomization, and at 8, 16, and 24 months after randomization. The primary outcome is severity of borderline symptomatology assessed with the Zanarini Rating Scale for borderline personality disorder. Secondary outcomes include self-harm incidents, functional impairment (Work and Social Adjustment Scale, Global Assessment of Functioning) and quality of life (Short-Form Health Survey 36). Severity of psychiatric symptoms (Symptom Checklist 90-R) will be included as an exploratory outcome. Measures of personality functioning, attachment, borderline symptoms, group alliance, and mentalization skills will be included to explore potential predictors and mechanisms of change.<h3 class=c-article__sub-heading data-test=abstract-sub-heading>Discussion</h3><p>This trial will provide evidence of the beneficial and harmful effects of short-term compared to long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder.<h3 class=c-article__sub-heading data-test=abstract-sub-heading>Trial registration</h3><p>ClinicalTrials.gov, <a href=https://clinicaltrials.gov/ct2/show/NCT03677037>NCT03677037</a>. Registered on September 19, 2018.</p></div></div></section>
 
 
 <p class="c-status-message c-status-message--info c-status-message--boxed">
 <svg class=c-status-message__icon width=24 height=24 aria-hidden=true focusable=false><use xlink:href=#icon-info></use></svg>
 <a href=https://link.springer.com/article/10.1186/s13063-019-3306-7/peer-review data-track=click data-track-category="article body" data-track-action="open peer review reports" data-track-label=10.1186/s13063-019-3306-7>Peer Review reports</a>
 </p>
 
 
 <div data-test=cobranding-download>
 
 </div>
 
 
 <section data-title=Background><div class=c-article-section id=Sec1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec1>Background</h2><div class=c-article-section__content id=Sec1-content><p>Borderline personality disorder is a psychiatric condition characterized by a pervasive pattern of symptoms such as interpersonal conflicts, identity diffusion, impulsivity, and emotional dysregulation [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington: American Psychiatric Pub; 2013." href=#ref-CR1 id=ref-link-section-d81762174e778>1</a>]. According to epidemiological studies, 1.6% of the general population suffer from borderline personality disorder [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Togersen J. In: Oldham J, Skodol AE, Bender DS, editors. Prevalence, Sociodemographics, and Functional Impairment, in Textbook of personality disorders. Washington DC: American Psychiatric Publishing; 2014. p. 109–31." href=#ref-CR2 id=ref-link-section-d81762174e781>2</a>]. In clinical populations, it is the most common personality disorder [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Togersen J. In: Oldham J, Skodol AE, Bender DS, editors. Prevalence, Sociodemographics, and Functional Impairment, in Textbook of personality disorders. Washington DC: American Psychiatric Publishing; 2014. p. 109–31." href=#ref-CR2 id=ref-link-section-d81762174e784>2</a>], with a prevalence of between 9% and 22% of all psychiatric outpatients [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Fossati A, et al. Patterns of covariation of DSM-IV personality disorders in a mixed psychiatric sample. Compr Psychiatry. 2000;41(3):206–15." href=#ref-CR3 id=ref-link-section-d81762174e787>3</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Zimmerman M, Rothschild L, Chelminski I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. Am J Psychiatr. 2005;162(10):1911–8." href=#ref-CR4 id=ref-link-section-d81762174e787_1>4</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 5" title="Korzekwa MI, et al. Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure. Compr Psychiatry. 2008;49(4):380–6." href=#ref-CR5 id=ref-link-section-d81762174e790>5</a>]. Borderline personality disorder is associated with high levels of psychiatric comorbidity, particularly depression, anxiety disorders, eating disorders, substance abuse [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Conklin CZ, Westen D. Borderline Personality Disorder in Clinical Practice. Am J Psychiatr. 2005;162:867–75." href=#ref-CR6 id=ref-link-section-d81762174e794>6</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Zanarini MC, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatr. 1998;155:1733–9." href=#ref-CR7 id=ref-link-section-d81762174e794_1>7</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 8" title="Trull TJ, et al. Borderline personality disorder and substance use disorders A review and integration. Clin Psychol Rev. 2000;20(2):235–53." href=#ref-CR8 id=ref-link-section-d81762174e797>8</a>], and other personality disorders [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 9" title="Barrachina J, et al. Axis II comorbidity in borderline personality disorder is influenced by sex, age, and clinical severity. Compr Psychiatry. 2011;52(6):725–30." href=#ref-CR9 id=ref-link-section-d81762174e800>9</a>]. Together, these findings emphasize the need for the development of efficacious and cost-effective treatments for this severe and highly prevalent disorder.<p>While pharmacological treatment may reduce some borderline-related symptoms, there is still no convincing evidence that it is suitable for treating all diagnostic criteria [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 10" title="Lieb K, et al. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry. 2010;196(1):4–12." href=#ref-CR10 id=ref-link-section-d81762174e806>10</a>]. Although further evidence is still warranted, psychotherapy continues to be the primary treatment of choice for borderline personality disorder [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 11" title="Bateman AW, Gunderson J, Mulder R. Treatment of personality disorder. Lancet. 2015;385(9969):735–43." href=#ref-CR11 id=ref-link-section-d81762174e809>11</a>]. During the last 10–15 years, studies have established the efficacy of different forms of intensive, specialized long-term psychotherapy modalities. These have recently been evaluated in a systematic review and meta-analysis exploring the efficacy of psychotherapies for borderline personality disorder, in which it was concluded that dialectical behavior therapy and psychodynamic therapies (transference focused therapy and mentalization-based therapy) significantly improved borderline-relevant outcomes [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 12" title="Cristea IA, et al. Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2017;74(4):319–28." href=#ref-CR12 id=ref-link-section-d81762174e812>12</a>]. However, no single treatment modality has been established as the primary treatment of choice.<p>Mentalization-based therapy (MBT) is a psychodynamic therapy rooted in attachment and cognitive theory [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatr. 2009;166(12):1355–64." href=#ref-CR13 id=ref-link-section-d81762174e818>13</a>], which was developed specifically for treating borderline personality disorder [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Bateman A, Fonagy P. Mentalization-based treatment for personality disorders: a practical guide. Oxford: Oxford University Press; 2016." href=#ref-CR14 id=ref-link-section-d81762174e821>14</a>]. Mentalization refers to the capacity to understand one’s own and others’ mental states. The theoretical assumption is that patients with borderline personality disorder are more vulnerable to lose this capacity when experiencing emotional distress. The MBT manual offers therapeutic techniques to identify these shifts and to bring the patient back into a mentalizing mode [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Bateman A, Fonagy P. Mentalization-based treatment for personality disorders: a practical guide. Oxford: Oxford University Press; 2016." href=#ref-CR14 id=ref-link-section-d81762174e824>14</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 15" title="Karterud S. Mentalization-Based Group Therapy (MBT-G): A theoretical, clinical, and research manual. Oxford: OUP Oxford; 2015." href=#ref-CR15 id=ref-link-section-d81762174e827>15</a>]. The therapy program consists of four basic components: (1) psycho-education, (2) case formulation, (3) group therapy, and (4) individual therapy. All of these aim to enhance the patient’s capacity to mentalize. Increasing mentalization skills is assumed to minimize borderline-related symptoms such as emotional dysregulation, impulsivity, and suicidal ideation. However, information about the mechanisms that produce a change in MBT, or in psychotherapy in general, is still limited [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 16" title="Vogt KS, Norman P. Is mentalization-based therapy effective in treating the symptoms of borderline personality disorder? A systematic review. Psychol Psychother. 2018. 
                  https://doi.org/10.1111/papt.12194
                  
                
                        " href=#ref-CR16 id=ref-link-section-d81762174e830>16</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 17" title="Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol. 2007;3:1–27." href=#ref-CR17 id=ref-link-section-d81762174e834>17</a>].<p>MBT for adult borderline personality disorder has been tested in cohort studies [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 18" title="Kvarstein EH, et al. Changing from a traditional psychodynamic treatment programme to mentalization-based treatment for patients with borderline personality disorder--does it make a difference? Psychol Psychother. 2015;88(1):71–86." href=#ref-CR18 id=ref-link-section-d81762174e840>18</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 19" title="Bales D, et al. Treatment outcome of 18-month, day hospital mentalization-based treatment (MBT) in patients with severe borderline personality disorder in the netherlands. J Personal Disord. 2012;26(4):568–82." href=#ref-CR19 id=ref-link-section-d81762174e843>19</a>] and one randomized but uncontrolled trial [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 20" title="Jorgensen CR, et al. Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial. Acta Psychiatr Scand. 2013;127(4):305–17." href=#ref-CR20 id=ref-link-section-d81762174e846>20</a>]. Two forms of MBT have been tested in randomized controlled trials: day hospital MBT [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 21" title="Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatr. 1999;156(10):1563–9." href=#ref-CR21 id=ref-link-section-d81762174e849>21</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 22" title="Laurenssen EM, Luyten P, Kikkert MJ, Westra D, Peen J, Soons MB, Dekker JJ. Day hospital mentalization-based treatment v. specialist treatment as usual in patients with borderline personality disorder: randomized controlled trial. Psychol Med. 2018;48(15):2522–29" href=#ref-CR22 id=ref-link-section-d81762174e852>22</a>] and intensive outpatient MBT [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatr. 2009;166(12):1355–64." href=#ref-CR13 id=ref-link-section-d81762174e856>13</a>], each lasting a maximum of 18 months. For a systematic review of the current evidence base of MBT for borderline personality disorder, see Vogt and Norman [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 16" title="Vogt KS, Norman P. Is mentalization-based therapy effective in treating the symptoms of borderline personality disorder? A systematic review. Psychol Psychother. 2018. 
                  https://doi.org/10.1111/papt.12194
                  
                
                        " href=#ref-CR16 id=ref-link-section-d81762174e859>16</a>].<p>Bateman and Fonagy [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatr. 2009;166(12):1355–64." href=#ref-CR13 id=ref-link-section-d81762174e866>13</a>] assessed the effects of intensive outpatient MBT in a randomized clinical trial, in which 134 participants with a confirmed borderline personality disorder diagnosis were randomized either to 18 months of outpatient MBT, combining weekly group and individual sessions with different therapists, or to structured clinical management. In this trial, MBT was superior to structured clinical management in terms of its effects on suicide attempts, severe incidents of self-harm, and on self-reported measures. Treatment effects were sustained at the 5-year follow-up [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 23" title="Bateman A, Fonagy P. 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatr. 2008;165(5):631–8." href=#ref-CR23 id=ref-link-section-d81762174e869>23</a>]. Nevertheless, only 134 participants were randomized, which questions whether the trial was powered to assess the chosen outcomes, and only 41 were assessed after 5 years. Further, the trial investigators were also the developers of MBT. Thus, the small sample size and the substantial problems with incomplete outcome data, especially at the long-term follow-up, are threats to the validity of the study.<p>However, while intensive outpatient MBT currently has empirical support as an 18-month program for borderline personality disorder, evidence that this is the optimal length of the intervention is not available. Consequently, MBT is now offered for different lengths of time (both shorter and longer) in outpatient settings around the world [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Bateman A, Fonagy P. Mentalization-based treatment for personality disorders: a practical guide. Oxford: Oxford University Press; 2016." href=#ref-CR14 id=ref-link-section-d81762174e875>14</a>]. Various other short-term psychotherapies for borderline personality disorder have already been developed and tested in randomized clinical trials, e.g., emotion regulation group therapy [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 24" title="Gratz KL, Tull MT, Levy R. Randomized controlled trial and uncontrolled 9-month follow-up of an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder. Psychol Med. 2014;44(10):2099–112." href=#ref-CR24 id=ref-link-section-d81762174e878>24</a>], systems training for emotional predictability and problem-solving [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 25" title="Blum N, St. John D, Pfohl B, Stuart S, McCormick B, Allen J, Arndt S, Black DW. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for Outpatients With Borderline Personality Disorder: A Randomized Controlled Trial and 1-Year Follow-Up. Am J Psychiatr. 2008;165:468–78." href=#ref-CR25 id=ref-link-section-d81762174e881>25</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 26" title="Bos EH, van Wel EB, Appelo MT, Verbraak MJ. A randomized controlled trial of a Dutch version of systems training for emotional predictability and problem solving for borderline personality disorder. J Nerv Ment Dis. 2010;198(4):299–304." href=#ref-CR26 id=ref-link-section-d81762174e884>26</a>], and brief dialectical behavior therapy skills training [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 27" title="McMain SF, et al. A randomized trial of brief dialectical behaviour therapy skills training in suicidal patients suffering from borderline disorder. Acta Psychiatr Scand. 2017;135(2):138–48." href=#ref-CR27 id=ref-link-section-d81762174e887>27</a>]. However, all the trials have either compared a short-term experimental group to a short-term control group or tested the short-term treatment as an adjunctive to treatment as usual. Thus, these trials do not provide guidance on evidence-based decisions regarding the optimal length of treatment for borderline patients. In addition, no empirical evidence is available to identify which subtypes of patients would benefit from short-term treatment and which would require more intensive treatment [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 28" title="McMain SF. Advances in the Treatment of Borderline Personality Disorder: An Introduction to the Special Issue. J Clin Psychol. 2015;71(8):741–6." href=#ref-CR28 id=ref-link-section-d81762174e891>28</a>].<p>We performed a preliminary literature search (PubMed and Cochrane Library) for trials comparing different lengths of psychotherapy for borderline personality disorder. No such trials were found. When we expanded our search terms to all types of psychiatric disorders, only few trials were identified [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 29" title="Knekt P, et al. Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up. Psychol Med. 2008;38(5):689–703." href=#ref-CR29 id=ref-link-section-d81762174e897>29</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 30" title="Lorentzen S, et al. Comparison of short- and long-term dynamic group psychotherapy: randomised clinical trial. Br J Psychiatry. 2013;203(3):280–7." href=#ref-CR30 id=ref-link-section-d81762174e900>30</a>]. We are currently working on a protocol for a more comprehensive systematic review, including a full assessment of risk of bias and a trial sequential analysis of short-term compared with long-term psychotherapy for all psychiatric disorders. The systematic review will be submitted for publication before data collection is completed in this trial.</p></div></div></section><section data-title=Methods/design><div class=c-article-section id=Sec2-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec2>Methods/design</h2><div class=c-article-section__content id=Sec2-content><h3 class=c-article__sub-heading id=Sec3>Objective</h3><p>The primary objective of this trial will be to evaluate the beneficial and harmful effects of short-term (20 weeks) MBT compared with long-term (14 months) MBT for adult outpatients with subthreshold or diagnosed borderline personality disorder. We will evaluate the treatments on the primary outcome (borderline symptomatology), secondary outcomes (self-harm incidents, quality of life, and functional impairment, and exploratory outcomes (psychiatric symptoms). Measures of personality functioning, attachment, borderline psychopathology, group cohesion, and mentalization skills will be included as predictor and mediator variables.<h3 class=c-article__sub-heading id=Sec4>Design</h3><p>We have designed an investigator-initiated parallel-group single-centre randomized clinical superiority trial of short-term versus long-term MBT for outpatients with subthreshold or diagnosed borderline personality disorder. The Consolidated Standards of Reporting Trials (CONSORT) flow chart for the trial is shown in Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 31" title="Boutron I, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295–309." href=#ref-CR31 id=ref-link-section-d81762174e926>31</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 32" title="Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol. 2001;1:2." href=#ref-CR32 id=ref-link-section-d81762174e929>32</a>]. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) participant timeline is given in Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig2>2</a>, and the SPIRIT checklist is given in Additional&nbsp;file&nbsp;<a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM1>1</a> [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 33" title="Chan A, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Ann Intern Med. 2013;158:200–7." href=#ref-CR33 id=ref-link-section-d81762174e939>33</a>].<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-1 data-title="Fig. 1"><figure><figcaption><b id=Fig1 class=c-article-section__figure-caption data-test=figure-caption-text>Fig. 1</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://link.springer.com/article/10.1186/s13063-019-3306-7/figures/1 rel=nofollow><picture><img aria-describedby=Fig1 src=data:null;base64, alt="figure 1" loading=lazy width=685 height=739 srcset sizes></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-1-desc><p>Consolidated Standards of Reporting Trials (CONSORT) flow chart</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://link.springer.com/article/10.1186/s13063-019-3306-7/figures/1 data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-2 data-title="Fig. 2"><figure><figcaption><b id=Fig2 class=c-article-section__figure-caption data-test=figure-caption-text>Fig. 2</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://link.springer.com/article/10.1186/s13063-019-3306-7/figures/2 rel=nofollow><picture><img aria-describedby=Fig2 src=data:null;base64, alt="figure 2" loading=lazy width=685 height=444 srcset sizes></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-2-desc><p>Participant timeline for the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://link.springer.com/article/10.1186/s13063-019-3306-7/figures/2 data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><p>We will consider for participation all patients referred to the trial site. Patients will be included in the trial, if they comply with the eligibility criteria listed in Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab1>1</a>. There are inclusion and exclusion criteria as part of the procedure for clinical intake at the trial site, and criteria specific to this trial. For a detailed overview of typical patient characteristics at the trial site, see Simonsen et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 34" title="Simonsen S, Heinskou T, Sørensen P, Folke S, Lau ME. Personality disorders: patient characteristics and level of outpatient treatment service. Nord J Psychiatry. 2017;71(5):325–31." href=#ref-CR34 id=ref-link-section-d81762174e982>34</a>].<div class=c-article-table data-test=inline-table data-container-section=table id=table-1><figure><figcaption class=c-article-table__figcaption><b id=Tab1 data-test=table-caption>Table 1 Eligibility criteria</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://link.springer.com/article/10.1186/s13063-019-3306-7/tables/1 aria-label="Full size table 1"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><p>We will include participants with at least subthreshold borderline personality disorder. According to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington: American Psychiatric Pub; 2013." href=#ref-CR1 id=ref-link-section-d81762174e1088>1</a>], the threshold for a full diagnosis is five out of nine diagnostic criteria. However, there is increasing evidence that even four confirmed diagnostic criteria are not qualitatively different from diagnosed borderline personality disorder in terms of impairment, and that the diagnostic threshold should be more inclusive than established by the DSM system to reflect the dimensionality of the construct [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 35" title="Clifton A, Pilkonis PA. Evidence for a single latent class of Diagnostic and Statistical Manual of Mental Disorders borderline personality pathology. Compr Psychiatry. 2007;48(1):70–8." href=#ref-CR35 id=ref-link-section-d81762174e1091>35</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 36" title="Tyrer P, Reed GM, Crawford MJ. Classification, assessment, prevalence, and effect of personality disorder. Lancet. 2015;385(9969):717–26." href=#ref-CR36 id=ref-link-section-d81762174e1094>36</a>]. For this reason, previous trials have included participants with at least a subthreshold diagnosis [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 24" title="Gratz KL, Tull MT, Levy R. Randomized controlled trial and uncontrolled 9-month follow-up of an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder. Psychol Med. 2014;44(10):2099–112." href=#ref-CR24 id=ref-link-section-d81762174e1097>24</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 37" title="Beck E, et al. Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial. Trials. 2016;17(1):314." href=#ref-CR37 id=ref-link-section-d81762174e1100>37</a>], and we will do the same in this trial.<h3 class=c-article__sub-heading id=Sec5>Trial site and personnel</h3><p>The trial site is the Outpatient Clinic for Personality Disorders at Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark (from now on referred to as “the clinic”). The clinic specializes in MBT for borderline personality disorder. Patients are referred from the Capital Region of Denmark via a central visitation unit, where they are initially screened for eligibility before referral to the clinic. Once referred to the clinic, psychiatrists and attending physicians will perform the initial selection and screening of a participant to the trial and collect informed consent. The principal investigator, sponsor-investigator, or a trained research assistant will then conduct the baseline assessments of the participant. All post-baseline assessments will be carried out by trial investigators who are blind to treatment allocation.<p>Trial therapists provide therapy to both the short-term and long-term treatment groups. Before commencing the trial, all trial therapists at the clinic will have received training in the short-term MBT program by trial investigators and national and international MBT specialists. The training covers relevant topics like case formulations, termination of psychotherapy, and case-specific supervision. The training will continue throughout the trial period. Therapist treatment fidelity will be rated by an independent certified rater. This will allow us to investigate whether the delivered interventions adhere to the MBT manual.<h3 class=c-article__sub-heading id=Sec6>Randomization</h3><p>Copenhagen Trial Unit, a Danish center for clinical intervention research, will be responsible for the central randomization. Trial investigators will call designated staff at Copenhagen Trial Unit using a central telephone to randomize eligible participants to either the experimental group or the control group with a 1:1 allocation according to a computer-generated allocation sequence with permuted blocks of various sizes generated by Copenhagen Trial Unit and unknown to the investigators, secretaries, and clinical staff at the trial site. This is done to eliminate any predictability in the random sequence. The randomization is stratified by (1) sex and (2) high/low scores on the primary outcome measure, the Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 38" title="Zanarini. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Personal Disord. 2003;17(3):233–42." href=#ref-CR38 id=ref-link-section-d81762174e1122>38</a>] at baseline.<h3 class=c-article__sub-heading id=Sec7>Interventions</h3><p>The short-term MBT program delivered in this trial is overall similar to the existing long-term program, but differs structurally in the following ways: (1) the short-term program is lower in treatment intensity (both duration and exposure), (2) the same therapists provide both group and individual sessions in the short-term program (conjoined psychotherapy), whereas the group therapy and individual therapy are provided by different therapists in the long-term program (combined psychotherapy), and (3) the short-term program is structured in closed groups, in which all participants start and finish the program together, whereas the long-term program is structured as slow-open groups, in which a new participant can enter a group when another finishes. Both interventions in this trial adhere to the treatment guidelines provided by the National Institute for Health and Care Excellence [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 39" title="National Insitute for Health and Care Excellence (NICE). Borderline Personality Disorder: the NICE Guideline on Treatment and Management. Br Psychol Soc R Coll Psychiatrists. 2009." href=#ref-CR39 id=ref-link-section-d81762174e1134>39</a>].<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec8>Experimental intervention</h4><p>The short-term MBT program is designed as a 20-week psychotherapy program consisting of five sessions of introductory MBT (MBT-I) followed by 15 sessions of group MBT (MBT-G) accompanied by conjoined individual sessions every second week and two psycho-educative meetings with participants and their relatives. Seven to nine participants and two therapists will be included in each short-term MBT group. The groups are closed to enhance cohesion between group participants. A total of 11 short-term MBT groups will be included in this trial.<p>Originally, MBT-I was a 12-session introductory psycho-educative program covering relevant topics like personality disorders, attachment, and mentalization [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 40" title="Karterud S, Bateman A. Manual for mentaliseringsbasert psykoedukativ gruppeterapi (MBT-I). Oslo: Gyldendal akademisk; 2011." href=#ref-CR40 id=ref-link-section-d81762174e1147>40</a>]. The original manual has been modified for our 5-week intervention. A copy of our modified manual is available upon request. After the completion of MBT-I, the same group of participants will move on to MBT-G, which consists of 15 sessions of mentalization-based psychotherapy in groups, as manualized by Bateman and Fonagy [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Bateman A, Fonagy P. Mentalization-based treatment for personality disorders: a practical guide. Oxford: Oxford University Press; 2016." href=#ref-CR14 id=ref-link-section-d81762174e1150>14</a>]. In our short-term MBT program, group sessions will be accompanied by individual psychotherapy every second week with one of the two group therapists. As part of the individual therapy, a case formulation will be prepared and subsequently shared by the participants in the group. The overall purpose of the individual sessions is for the therapist and participant to develop a consensus of the participant’s main difficulties and to establish psychotherapeutic focus points in the group therapy. Furthermore, participants and relatives will be invited to two psycho-educative meetings hosted by the therapists at the beginning of the treatment program to enhance the mentalization work at home. The participants in the short-term MBT program will furthermore be offered three individual follow-up sessions after the end of treatment.<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec9>Control intervention</h4><p>Long-term MBT is organized as a 14-month program and has been implemented at the clinic for the past 7 years. All participants randomized to long-term MBT will initially enter a 6-week MBT-I program manualized by Karterud and Bateman [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 40" title="Karterud S, Bateman A. Manual for mentaliseringsbasert psykoedukativ gruppeterapi (MBT-I). Oslo: Gyldendal akademisk; 2011." href=#ref-CR40 id=ref-link-section-d81762174e1161>40</a>] and modified for our 6-week intervention in collaboration with the authors. New MBT-I groups commence every time new participants are recruited and randomized to long-term MBT. A maximum of 12 participants can enter an MBT-I group. When MBT-I finishes, participants will be allocated to one of eight slow-open MBT treatment groups. MBT-G is then organized as 12 months of weekly group therapy sessions, also manualized by Bateman and Fonagy [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Bateman A, Fonagy P. Mentalization-based treatment for personality disorders: a practical guide. Oxford: Oxford University Press; 2016." href=#ref-CR14 id=ref-link-section-d81762174e1164>14</a>]. In the long-term MBT program, group sessions will be accompanied by combined individual MBT sessions every 2 weeks throughout the program. As part of the individual therapy, a case formulation will be developed and subsequently shared with the group by the participant. Furthermore, participants and relatives will also be invited to two psycho-educative meetings hosted by the therapists to enhance the mentalization work at home. When a participant drops out or completes MBT-G, a new participant can start in the group. This procedure continues until the target sample size has been randomized to the long-term MBT program. The participants in the long-term MBT program will also be offered three individual follow-up sessions after the end of treatment.<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec10>Concomitant interventions</h4><p>Participants who are receiving psychotropic treatment will be allowed to continue their medical treatment while participating in the trial. The medical protocol will follow national as well as international medical recommendations for the treatment of borderline personality disorder and comorbid disorders [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 39" title="National Insitute for Health and Care Excellence (NICE). Borderline Personality Disorder: the NICE Guideline on Treatment and Management. Br Psychol Soc R Coll Psychiatrists. 2009." href=#ref-CR39 id=ref-link-section-d81762174e1175>39</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 41" title="Sundhedsstyrelsen, National klinisk retningslinje for behandling af emotionel ustabil personlighedsstruktur, borderline type. 2015." href=#ref-CR41 id=ref-link-section-d81762174e1178>41</a>]. Psychiatrists or attending physicians at the clinic will assess the need for additional psychotropic treatment and are asked to adhere to the guidelines. All participants, regardless of treatment condition, will be asked about their current medication by trial personnel during trial interviews to allow us to measure any potential differences in the use of psychotropic medication between the groups.<h3 class=c-article__sub-heading id=Sec11>Baseline assessment at trial intake</h3><p>Baseline assessments will be carried out prior to randomization by the principal investigator, the sponsor-investigator, and a trained research assistant, all of whom are also clinical psychologists. <i>General psychopathology</i> will be assessed with the Mini International Neuropsychiatric Interview (MINI) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 42" title="Lecrubier Y, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry. 1997;12:224–31." href=#ref-CR42 id=ref-link-section-d81762174e1193>42</a>]. <i>Personality disorders</i> will be assessed with the Structured Clinical Interview for DSM-V Personality Disorders (SCID-5-PD), formerly known as SCID-II [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 43" title="First MB, et al. The Structured Clinical Interview for DSM-II-R Personality Disorders (SCID-II). Part II: Multi-site test-retest reliability study. J Personal Disord. 1995;9(2):92–104." href=#ref-CR43 id=ref-link-section-d81762174e1199>43</a>]. The SCID-5-PD is considered the gold standard for clinician-administered semi-structured interviews designed to assess personality disorders according to DSM-V criteria [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 44" title="Lobbestael J, Leurgans M, Arntz A. Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II). Clin Psychol Psychother. 2011;18(1):75–9." href=#ref-CR44 id=ref-link-section-d81762174e1202>44</a>].<h3 class=c-article__sub-heading id=Sec12>Outcomes</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec13>Primary outcome</h4><p>The primary outcome is the severity of borderline symptomatology assessed with the ZAN-BPD [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 38" title="Zanarini. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Personal Disord. 2003;17(3):233–42." href=#ref-CR38 id=ref-link-section-d81762174e1217>38</a>], which is a clinician-administered scale for the assessment of change in borderline psychopathology over time. Each of the nine borderline personality disorder criteria are rated on a 0 to 4 anchored scale reflecting the severity of symptoms. The rating is intended to reflect both the frequency and the severity of borderline psychopathology. The interview provides a total score of borderline psychopathology ranging from 0 to 36. ZAN-BPD will be assessed by investigators blind to treatment allocation at baseline, and at the 8-, 16-, and 24-month follow-ups. We will video-record interviews to allow an assessment of inter-rater reliability based on the intraclass correlation coefficient. The results will be evaluated using the guidelines provided by Cicchetti [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 45" title="Cicchetti DV. Guidelines, Criteria, an Rules of Thumb for Evaluating Normed and Standardized Assessment Instruments in Psychology. Psychol Assess. 1994;6(4):284–90." href=#ref-CR45 id=ref-link-section-d81762174e1220>45</a>].<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec14>Secondary outcomes</h4><p><i>Functional impairment</i> will be assessed with the Work and Social Adjustment Scale (WSAS) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 46" title="Pedersen G, Kvarstein EH, Wilberg T. The Work and Social Adjustment Scale: Psychometric properties and validity among males and females, and outpatients with and without personality disorders. Personal Ment Health. 2017;11(4):215–28." href=#ref-CR46 id=ref-link-section-d81762174e1233>46</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 47" title="Miles HH, Barrabee EL, Finesinger JE. Evaluation of psychotherapy: with a follow up study of 62 cases of anxiety neurosis. Psychosom Med. 1951 Mar-Apr;13(2):83-105." href=#ref-CR47 id=ref-link-section-d81762174e1236>47</a>]. This self-report scale will be assessed at baseline, and at the 8-, 16-, and 24-month follow-ups. <i>Quality of life</i> will be assessed with the Short-Form Health Survey (SF-36) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 48" title="Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection. Med Care. 1992;30(6):473–83." href=#ref-CR48 id=ref-link-section-d81762174e1242>48</a>], which consists of a mental and a physical component. We will use the mental component as a secondary outcome and the physical component as an exploratory outcome. This self-report scale will be given at baseline, and at the 8-, 16-, and 24-month follow-ups. <i>Global functioning</i> will be measured with the Global Assessment of Functioning (GAF) split version [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 49" title="Jones SH, et al. Reliability and Validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 1995;166:654–9." href=#ref-CR49 id=ref-link-section-d81762174e1249>49</a>]. GAF will be assessed by investigators blind to treatment allocation at baseline, and at the 8-, 16-, and 24-month follow-ups. Inter-rater reliability will be calculated using the previously mentioned guidelines. <i>Severe self-harm</i> (dichotomous data) will be measured as the proportion of participants with severe self-harm defined as deliberate acts of self-harm resulting in visible tissue damage. Self-harm will be assessed by investigators blind to treatment allocation using the Suicide and Self-harm Inventory (SSHI) (citation) at baseline, and at the 8-, 16-, and 24-month follow-ups.<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec15>Exploratory outcomes</h4><p><i>Symptom distress</i> will be measured with the Global Severity Index (GSI) of the Symptom Checklist 90-R (SCL-90-R) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 50" title="Derogatis LR, Cleary PA. Confirmation of the dimensional structure of the SCL-90: a study in construct validation. J Clin Psychol. 1977;33(4):981–9." href=#ref-CR50 id=ref-link-section-d81762174e1265>50</a>]. SCL-90-R will be given at baseline, and at the 8-, 16-, and 24-month follow-ups.<h3 class=c-article__sub-heading id=Sec16>Potential predictors and mediators</h3><p>Questionnaires are given at baseline and every fourth week throughout the intervention period for both intervention groups to allow us to explore predictors and mechanisms of change. In a separate statistical analysis plan, which will be submitted for publication before data collection is completed in this trial, we will describe how these exploratory analyses will be performed. The following predictors and mediators will be investigated.<p><i>Personality functioning</i> will be assessed with the Levels of Personality Functioning Scale, Brief Form (LPFS-BF) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 51" title="Hutsebaut J, Feensta D, Kamphuis J. Development and Preliminary Psychometric Evaluation of a Brief Self-Report Questionnaire for the Assessment of the DSM–5 Level of Personality Functioning Scale: The LPFS Brief Form (LPFS-BF). Personal Disord Theory Res Treat. 2016;7(2):192–4." href=#ref-CR51 id=ref-link-section-d81762174e1282>51</a>], which is a newly developed brief 12-item self-report questionnaire assessing levels of personality functioning according to the DSM-V alternative model for personality disorders. <i>Attachment</i> will be assessed with the brief self-report Relationship Questionnaire (RQ), which gives continuous and categorical ratings of the four attachment styles [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 52" title="Bartholomew K, Horowitz LM. Attachment Styles Among Young Adults: A Test of a Four-Category Model. J Pers Soc Psychol. 1991;61(2):226–44." href=#ref-CR52 id=ref-link-section-d81762174e1288>52</a>]. <i>Borderline symptomatology</i> will be assessed using the Zanarini Rating Scale for Borderline Personality Disorder, Self-Report Version (ZAN-BPD-SRV) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 53" title="Zanarini, et al. Development of the self-report version of the Zanarini Rating Scale for Borderline Personality Disorder. Personal Ment Health. 2015;9(4):243–9." href=#ref-CR53 id=ref-link-section-d81762174e1294>53</a>]. <i>Group alliance</i> will be assessed using the 12-item version of the Group Questionnaire (GQ) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 54" title="Krogel J, et al. The Group Questionnaire: a clinical and empirically derived measure of group relationship. Psychother Res. 2013;23(3):344–54." href=#ref-CR54 id=ref-link-section-d81762174e1301>54</a>], which is a brief self-report measure of the three core components of group alliance: alliance to the other participants, alliance to the therapists, and group cohesion as a whole. <i>Mentalization skills</i> will be assessed with the 15-item Mentalization Questionnaire (MZQ) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 55" title="Hausberg M, Schulz H, Piegler T, Happach C, Klöpper M, Brütt A, et al. Is a self-rated instrument appropriate to assess mentalization in patients with mental disorders? Development and first validation of the Mentalization Questionnaire (MZQ). Psychother Res. 2012;22(6):699–709." href=#ref-CR55 id=ref-link-section-d81762174e1307>55</a>].<p>For an overview of all measures and the corresponding time of assessment, see Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab2>2</a>.<div class=c-article-table data-test=inline-table data-container-section=table id=table-2><figure><figcaption class=c-article-table__figcaption><b id=Tab2 data-test=table-caption>Table 2 Assessments administered at baseline and each follow-up point throughout the trial</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://link.springer.com/article/10.1186/s13063-019-3306-7/tables/2 aria-label="Full size table 2"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><h3 class=c-article__sub-heading id=Sec17>Blinding</h3><p>Trial participants and therapists will not be blind to treatment allocation. This is due to the difficulties of implementing an efficient blinding procedure in psychotherapy trials. Baseline assessments will be done before allocation of participants, and the outcome assessments will be performed by blinded assessors. Participants will be instructed to withhold information of their allocation group when assessed. The statistical analyses will be conducted by blinded external statisticians from Copenhagen Trial Unit with the intervention groups coded as A and B. The steering committee will write and agree on two abstracts while the blinding is intact; one assuming the experimental intervention group is A and the control intervention group is B, and the other assuming the opposite. After this, the randomization code will be broken [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 56" title="Gotzsche PC. Blinding during data analysis and writing of manuscripts. Control Clin Trials. 1996;17(4):285–90 discussion 290-3." href=#ref-CR56 id=ref-link-section-d81762174e1469>56</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 57" title="Jarvinen TL, et al. Blinded interpretation of study results can feasibly and effectively diminish interpretation bias. J Clin Epidemiol. 2014;67(7):769–72." href=#ref-CR57 id=ref-link-section-d81762174e1472>57</a>].<h3 class=c-article__sub-heading id=Sec18>Participant discontinuation and withdrawal</h3><p>Participants can withdraw from the trial at any time without giving a reason and without consequences for future treatment at the clinic. To secure data for the trial, a trial investigator will contact the participant and ask what aspects of the trial the participant wishes to withdraw from: (1) the trial intervention or control group, (2) the assessment interviews, or (3) use of already collected data in analyses. If the participant specifies that they wish to withdraw fully and thereby withdraw from all the points above, their data will be deleted and not used in any analysis. The trial investigator will encourage the participant to continue attending the follow-up assessments.<h3 class=c-article__sub-heading id=Sec19>Data management</h3><p>The data in this trial will be collected using electronic case report forms developed in the data collection system REDCap. The system has been approved by the Danish Data Protection Agency and fulfills the requirements for data security. Data from the interviews will be entered directly into REDCap on a tablet, and all self-report measures will be collected from REDCap. For a detailed overview of outcome measures and data collection time points, see Table <a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab2>2</a>. The only source data are participants’ signed consent forms.<p>Student assistants employed in the research department but not otherwise involved in the trial will make sure that all self-report measures are sent to participants at the right times, and that the data are complete for all participants enrolled in the trial. The REDCap database has an integrated audit trail to document any access to and changes of the data. The validated data will be exported to SAS for further statistical analyses by statisticians from Copenhagen Trial Unit.<h3 class=c-article__sub-heading id=Sec20>Statistical plan and data analysis</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec21>Sample size</h4><p>The sample size was determined by the predicted change in the primary outcome measure, ZAN-BPD. A 3.5-point superiority margin is considered to be the minimal important difference. Consistent with previous trials that have used ZAN-BPD as an outcome measure for a patient group like ours [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 24" title="Gratz KL, Tull MT, Levy R. Randomized controlled trial and uncontrolled 9-month follow-up of an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder. Psychol Med. 2014;44(10):2099–112." href=#ref-CR24 id=ref-link-section-d81762174e1510>24</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 58" title="Priebe S, et al. Effectiveness and cost-effectiveness of dialectical behaviour therapy for self-harming patients with personality disorder: a pragmatic randomised controlled trial. Psychother Psychosom. 2012;81(6):356–65." href=#ref-CR58 id=ref-link-section-d81762174e1513>58</a>], we expect a standard deviation of 8. With power set at 80% and alpha set at 5% two-tailed, a sample size of 83 participants is needed in each treatment group, corresponding to a total of 166 participants.<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec22>Statistical methods</h4><p>All continuous outcomes will be assessed using linear regression and dichotomous outcomes will be analyzed using logistic regression. The analyses will be based on an intention-to-treat population and will primarily be adjusted for the baseline value of the outcome of interest and the stratification variables used in the randomization. We will secondly adjust all analyses for the following design variables: age (18–30 and 30–60) and functional impairment as assessed with the overall baseline GAF score (0–48 and 49–100) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 34" title="Simonsen S, Heinskou T, Sørensen P, Folke S, Lau ME. Personality disorders: patient characteristics and level of outpatient treatment service. Nord J Psychiatry. 2017;71(5):325–31." href=#ref-CR34 id=ref-link-section-d81762174e1524>34</a>].<p>We will use a five-step procedure [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 59" title="Jakobsen JC, et al. The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol. 2014;14:34." href=#ref-CR59 id=ref-link-section-d81762174e1530>59</a>] to assess if the thresholds for statistical and clinical significance are crossed and we will handle missing data according to the procedure suggested by Jakobsen et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 60" title="Jakobsen JC, et al. When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162." href=#ref-CR60 id=ref-link-section-d81762174e1533>60</a>]. A detailed statistical analysis plan will be published before the analyses commence, in which we will provide a detailed description of all primary, secondary, and exploratory analyses. All analyses will be performed blinded with the two intervention groups concealed as A and B.<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec23>Interim analyses</h4><p>An external data safety monitoring committee will perform interim analyses when 50% of the data have been collected according to the good clinical practice guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 61" title="Englev E, Petersen KP. ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives. Dan Med J. 2003;165(16):1659–62." href=#ref-CR61 id=ref-link-section-d81762174e1544>61</a>]. It will decide whether the trial should stop or carry on. Early stopping criteria will follow the recommendations of Jakobsen et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 59" title="Jakobsen JC, et al. The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol. 2014;14:34." href=#ref-CR59 id=ref-link-section-d81762174e1547>59</a>].</p></div></div></section><section data-title=Discussion><div class=c-article-section id=Sec24-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec24>Discussion</h2><div class=c-article-section__content id=Sec24-content><p>This trial will provide evidence of the beneficial and harmful effects of short-term compared to long-term MBT for outpatients with subthreshold or diagnosed borderline personality disorder. To the best of our knowledge, short-term MBT has never been tested before. Gaining more information on how different lengths of treatment work for specific subtypes of patients may help to minimize the potential burden from long-term psychotherapy for some, while at the same time it may identify subtypes of patients for whom short-term psychotherapy is contraindicated. This knowledge may enhance the cost-effectiveness of treatment options for borderline personality disorder. Further, this trial may provide information on the potential predictors and mediators of treatment response.<p>The present trial has several strengths. First, it has a high degree of external validity because of the relatively inclusive eligibility criteria. Second, the methodology is based on CONSORT, and was predefined and described in detail before randomization began, including, e.g., blinding of all possible parties and implementation of a central randomization system both for generating an allocation sequence and for concealing allocation. Third, the implementation of systematic treatment fidelity ratings allows us to investigate treatment fidelity in both groups.<p>Our trial also has limitations. First, no systematic review of the effects of short-term compared to long-term psychotherapy for psychiatric disorders is currently available. As mentioned earlier, we are currently performing such a review. Second, the long-term MBT intervention, which is 14 months of treatment in this trial, diverges in intensity (both duration and exposure) from the original 18-month program [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatr. 2009;166(12):1355–64." href=#ref-CR13 id=ref-link-section-d81762174e1566>13</a>]. This is due to the fixed length of the treatment packages, which have been implemented in the Danish mental health care system. Third, we cannot account for any potential confounding variables because of the structural differences between the groups: the short-term MBT program is closed and conjoined, whereas the long-term program is slow-open and combined.<h3 class=c-article__sub-heading id=Sec25>Dissemination policy</h3><p>The Danish population will be informed of the trial as well as its final results through national media. The results of the trial will be presented at all outpatient clinics treating borderline personality disorder in the Mental Health Services, Capital Region of Denmark, by the principal investigator or sponsor-investigator. The final and interim results will be presented at national and international conferences. Further, associations for patients and relatives will be informed about the results of the trial and its future implications. The trial results will be written up by the steering committee and will be published in international peer-reviewed journals. The government of Denmark will be informed of the results before a press release is issued but will have no influence on the reporting of results.<h3 class=c-article__sub-heading id=Sec26>Trial status</h3><p>The current protocol is version 1, dated 9 October 2018. The first participant was enrolled on 24 September 2018. Recruitment is expected to be completed by September 1, 2020</p></div></div></section>
 
 
 <section data-title=Abbreviations><div class=c-article-section id=abbreviations-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=abbreviations>Abbreviations</h2><div class=c-article-section__content id=abbreviations-content><dl class=c-abbreviation_list><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>CONSORT:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Consolidated Standards of Reporting Trials</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>DSM-V:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Diagnostic and Statistical Manual of Mental Disorders, 5th edition</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>GAF:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Global Assessment of Functioning</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>GQ:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Group Questionnaire</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>GSI:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Global Severity Index</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>LPFS-BF:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Levels of Personality Functioning Scale, Brief Form</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>MBT:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Mentalization-based therapy</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>MBT-G:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Mentalization-based group therapy</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>MBT-I:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Introduction to Mentalization-Based Therapy</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>MINI:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Mini International Neuropsychiatric Interview</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>MZQ:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Mentalization Questionnaire</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>RQ:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Relationship Questionnaire</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>SCID-5-PD:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Structured Clinical Interview for DSM-V Personality Disorders</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>SCL-90-R:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Symptom Checklist 90-R</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>SF-36:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Short-Form Health Survey 36</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>SPIRIT:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Standard Protocol Items: Recommendations for Interventional Trials</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>SSHI:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Suicide and Self-Harm Inventory</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>WSAS:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Work and Social Adjustment Scale</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>ZAN-BPD:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Zanarini Rating Scale for Borderline Personality Disorder</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>ZAN-BPD-SRV:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Zanarini Rating Scale for Borderline Personality Disorder, Self-Report Version</p>
 </dl></div></div></section><div id=MagazineFulltextArticleBodySuffix><section aria-labelledby=Bib1 data-title=References><div class=c-article-section id=Bib1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Bib1>References</h2><div class=c-article-section__content id=Bib1-content><div data-container-section=references><ol class=c-article-references><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=1.><p class=c-article-references__text id=ref-CR1>American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington: American Psychiatric Pub; 2013.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=2.><p class=c-article-references__text id=ref-CR2>Togersen J. In: Oldham J, Skodol AE, Bender DS, editors. Prevalence, Sociodemographics, and Functional Impairment, in Textbook of personality disorders. Washington DC: American Psychiatric Publishing; 2014. p. 109–31.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Prevalence%2C%20Sociodemographics%2C%20and%20Functional%20Impairment%2C%20in%20Textbook%20of%20personality%20disorders&amp;pages=109-131&amp;publication_year=2014&amp;author=Togersen%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=3.><p class=c-article-references__text id=ref-CR3>Fossati A, et al. Patterns of covariation of DSM-IV personality disorders in a mixed psychiatric sample. Compr Psychiatry. 2000;41(3):206–15.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DC%2BD3cvlslaqtg%3D%3D aria-label="CAS reference 3">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10834630" aria-label="PubMed reference 3">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS0010-440X%2800%2990049-X aria-label="Article reference 3">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=Patterns%20of%20covariation%20of%20DSM-IV%20personality%20disorders%20in%20a%20mixed%20psychiatric%20sample&amp;journal=Compr%20Psychiatry&amp;volume=41&amp;issue=3&amp;pages=206-215&amp;publication_year=2000&amp;author=Fossati%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=4.><p class=c-article-references__text id=ref-CR4>Zimmerman M, Rothschild L, Chelminski I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. Am J Psychiatr. 2005;162(10):1911–8.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16199838" aria-label="PubMed reference 4">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1176%2Fappi.ajp.162.10.1911 aria-label="Article reference 4">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20prevalence%20of%20DSM-IV%20personality%20disorders%20in%20psychiatric%20outpatients&amp;journal=Am%20J%20Psychiatr&amp;volume=162&amp;issue=10&amp;pages=1911-1918&amp;publication_year=2005&amp;author=Zimmerman%2CM&amp;author=Rothschild%2CL&amp;author=Chelminski%2CI">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=5.><p class=c-article-references__text id=ref-CR5>Korzekwa MI, et al. Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure. Compr Psychiatry. 2008;49(4):380–6.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18555059" aria-label="PubMed reference 5">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.comppsych.2008.01.007 aria-label="Article reference 5">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Estimating%20the%20prevalence%20of%20borderline%20personality%20disorder%20in%20psychiatric%20outpatients%20using%20a%20two-phase%20procedure&amp;journal=Compr%20Psychiatry&amp;volume=49&amp;issue=4&amp;pages=380-386&amp;publication_year=2008&amp;author=Korzekwa%2CMI">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=6.><p class=c-article-references__text id=ref-CR6>Conklin CZ, Westen D. Borderline Personality Disorder in Clinical Practice. Am J Psychiatr. 2005;162:867–75.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1176%2Fappi.ajp.162.5.867 aria-label="Article reference 6">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Borderline%20Personality%20Disorder%20in%20Clinical%20Practice&amp;journal=Am%20J%20Psychiatr&amp;volume=162&amp;pages=867-875&amp;publication_year=2005&amp;author=Conklin%2CCZ&amp;author=Westen%2CD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=7.><p class=c-article-references__text id=ref-CR7>Zanarini MC, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatr. 1998;155:1733–9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DyaK1M%2Fls12iug%3D%3D aria-label="CAS reference 7">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9842784" aria-label="PubMed reference 7">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1176%2Fajp.155.12.1733 aria-label="Article reference 7">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Axis%20I%20comorbidity%20of%20borderline%20personality%20disorder&amp;journal=Am%20J%20Psychiatr&amp;volume=155&amp;pages=1733-1739&amp;publication_year=1998&amp;author=Zanarini%2CMC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=8.><p class=c-article-references__text id=ref-CR8>Trull TJ, et al. Borderline personality disorder and substance use disorders A review and integration. Clin Psychol Rev. 2000;20(2):235–53.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DC%2BD3c7os1aktQ%3D%3D aria-label="CAS reference 8">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10721499" aria-label="PubMed reference 8">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS0272-7358%2899%2900028-8 aria-label="Article reference 8">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Borderline%20personality%20disorder%20and%20substance%20use%20disorders%20A%20review%20and%20integration&amp;journal=Clin%20Psychol%20Rev&amp;volume=20&amp;issue=2&amp;pages=235-253&amp;publication_year=2000&amp;author=Trull%2CTJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=9.><p class=c-article-references__text id=ref-CR9>Barrachina J, et al. Axis II comorbidity in borderline personality disorder is influenced by sex, age, and clinical severity. Compr Psychiatry. 2011;52(6):725–30.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21349508" aria-label="PubMed reference 9">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.comppsych.2010.11.009 aria-label="Article reference 9">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Axis%20II%20comorbidity%20in%20borderline%20personality%20disorder%20is%20influenced%20by%20sex%2C%20age%2C%20and%20clinical%20severity&amp;journal=Compr%20Psychiatry&amp;volume=52&amp;issue=6&amp;pages=725-730&amp;publication_year=2011&amp;author=Barrachina%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=10.><p class=c-article-references__text id=ref-CR10>Lieb K, et al. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry. 2010;196(1):4–12.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20044651" aria-label="PubMed reference 10">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1192%2Fbjp.bp.108.062984 aria-label="Article reference 10">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Pharmacotherapy%20for%20borderline%20personality%20disorder%3A%20Cochrane%20systematic%20review%20of%20randomised%20trials&amp;journal=Br%20J%20Psychiatry&amp;volume=196&amp;issue=1&amp;pages=4-12&amp;publication_year=2010&amp;author=Lieb%2CK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=11.><p class=c-article-references__text id=ref-CR11>Bateman AW, Gunderson J, Mulder R. Treatment of personality disorder. Lancet. 2015;385(9969):735–43.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25706219" aria-label="PubMed reference 11">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS0140-6736%2814%2961394-5 aria-label="Article reference 11">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Treatment%20of%20personality%20disorder&amp;journal=Lancet&amp;volume=385&amp;issue=9969&amp;pages=735-743&amp;publication_year=2015&amp;author=Bateman%2CAW&amp;author=Gunderson%2CJ&amp;author=Mulder%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=12.><p class=c-article-references__text id=ref-CR12>Cristea IA, et al. Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2017;74(4):319–28.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28249086" aria-label="PubMed reference 12">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1001%2Fjamapsychiatry.2016.4287 aria-label="Article reference 12">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Efficacy%20of%20Psychotherapies%20for%20Borderline%20Personality%20Disorder%3A%20A%20Systematic%20Review%20and%20Meta-analysis&amp;journal=JAMA%20Psychiatry&amp;volume=74&amp;issue=4&amp;pages=319-328&amp;publication_year=2017&amp;author=Cristea%2CIA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=13.><p class=c-article-references__text id=ref-CR13>Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatr. 2009;166(12):1355–64.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19833787" aria-label="PubMed reference 13">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1176%2Fappi.ajp.2009.09040539 aria-label="Article reference 13">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Randomized%20controlled%20trial%20of%20outpatient%20mentalization-based%20treatment%20versus%20structured%20clinical%20management%20for%20borderline%20personality%20disorder&amp;journal=Am%20J%20Psychiatr&amp;volume=166&amp;issue=12&amp;pages=1355-1364&amp;publication_year=2009&amp;author=Bateman%2CA&amp;author=Fonagy%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=14.><p class=c-article-references__text id=ref-CR14>Bateman A, Fonagy P. Mentalization-based treatment for personality disorders: a practical guide. Oxford: Oxford University Press; 2016.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=15.><p class=c-article-references__text id=ref-CR15>Karterud S. Mentalization-Based Group Therapy (MBT-G): A theoretical, clinical, and research manual. Oxford: OUP Oxford; 2015.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=16.><p class=c-article-references__text id=ref-CR16>Vogt KS, Norman P. Is mentalization-based therapy effective in treating the symptoms of borderline personality disorder? A systematic review. Psychol Psychother. 2018. <a href=https://doi.org/10.1111/papt.12194>https://doi.org/10.1111/papt.12194</a>
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=17.><p class=c-article-references__text id=ref-CR17>Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol. 2007;3:1–27.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17716046" aria-label="PubMed reference 17">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1146%2Fannurev.clinpsy.3.022806.091432 aria-label="Article reference 17">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=Mediators%20and%20mechanisms%20of%20change%20in%20psychotherapy%20research&amp;journal=Annu%20Rev%20Clin%20Psychol&amp;volume=3&amp;pages=1-27&amp;publication_year=2007&amp;author=Kazdin%2CAE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=18.><p class=c-article-references__text id=ref-CR18>Kvarstein EH, et al. Changing from a traditional psychodynamic treatment programme to mentalization-based treatment for patients with borderline personality disorder--does it make a difference? Psychol Psychother. 2015;88(1):71–86.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25045028" aria-label="PubMed reference 18">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1111%2Fpapt.12036 aria-label="Article reference 18">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Changing%20from%20a%20traditional%20psychodynamic%20treatment%20programme%20to%20mentalization-based%20treatment%20for%20patients%20with%20borderline%20personality%20disorder--does%20it%20make%20a%20difference%3F&amp;journal=Psychol%20Psychother&amp;volume=88&amp;issue=1&amp;pages=71-86&amp;publication_year=2015&amp;author=Kvarstein%2CEH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=19.><p class=c-article-references__text id=ref-CR19>Bales D, et al. Treatment outcome of 18-month, day hospital mentalization-based treatment (MBT) in patients with severe borderline personality disorder in the netherlands. J Personal Disord. 2012;26(4):568–82.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1521%2Fpedi.2012.26.4.568 aria-label="Article reference 19">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=Treatment%20outcome%20of%2018-month%2C%20day%20hospital%20mentalization-based%20treatment%20%28MBT%29%20in%20patients%20with%20severe%20borderline%20personality%20disorder%20in%20the%20netherlands&amp;journal=J%20Personal%20Disord&amp;volume=26&amp;issue=4&amp;pages=568-582&amp;publication_year=2012&amp;author=Bales%2CD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=20.><p class=c-article-references__text id=ref-CR20>Jorgensen CR, et al. Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial. Acta Psychiatr Scand. 2013;127(4):305–17.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DC%2BC38fosVGmsA%3D%3D aria-label="CAS reference 20">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22897123" aria-label="PubMed reference 20">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1111%2Fj.1600-0447.2012.01923.x aria-label="Article reference 20">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Outcome%20of%20mentalization-based%20and%20supportive%20psychotherapy%20in%20patients%20with%20borderline%20personality%20disorder%3A%20a%20randomized%20trial&amp;journal=Acta%20Psychiatr%20Scand&amp;volume=127&amp;issue=4&amp;pages=305-317&amp;publication_year=2013&amp;author=Jorgensen%2CCR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=21.><p class=c-article-references__text id=ref-CR21>Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatr. 1999;156(10):1563–9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DyaK1Mvks1Cgtw%3D%3D aria-label="CAS reference 21">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10518167" aria-label="PubMed reference 21">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1176%2Fajp.156.10.1563 aria-label="Article reference 21">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Effectiveness%20of%20partial%20hospitalization%20in%20the%20treatment%20of%20borderline%20personality%20disorder%3A%20a%20randomized%20controlled%20trial&amp;journal=Am%20J%20Psychiatr&amp;volume=156&amp;issue=10&amp;pages=1563-1569&amp;publication_year=1999&amp;author=Bateman%2CA&amp;author=Fonagy%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=22.><p class=c-article-references__text id=ref-CR22>Laurenssen EM, Luyten P, Kikkert MJ, Westra D, Peen J, Soons MB, Dekker JJ. Day hospital mentalization-based treatment v. specialist treatment as usual in patients with borderline personality disorder: randomized controlled trial. Psychol Med. 2018;48(15):2522–29</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=23.><p class=c-article-references__text id=ref-CR23>Bateman A, Fonagy P. 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatr. 2008;165(5):631–8.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18347003" aria-label="PubMed reference 23">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1176%2Fappi.ajp.2007.07040636 aria-label="Article reference 23">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=8-year%20follow-up%20of%20patients%20treated%20for%20borderline%20personality%20disorder%3A%20mentalization-based%20treatment%20versus%20treatment%20as%20usual&amp;journal=Am%20J%20Psychiatr&amp;volume=165&amp;issue=5&amp;pages=631-638&amp;publication_year=2008&amp;author=Bateman%2CA&amp;author=Fonagy%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=24.><p class=c-article-references__text id=ref-CR24>Gratz KL, Tull MT, Levy R. Randomized controlled trial and uncontrolled 9-month follow-up of an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder. Psychol Med. 2014;44(10):2099–112.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DC%2BC3sbjtFGltA%3D%3D aria-label="CAS reference 24">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23985088" aria-label="PubMed reference 24">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1017%2FS0033291713002134 aria-label="Article reference 24">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=Randomized%20controlled%20trial%20and%20uncontrolled%209-month%20follow-up%20of%20an%20adjunctive%20emotion%20regulation%20group%20therapy%20for%20deliberate%20self-harm%20among%20women%20with%20borderline%20personality%20disorder&amp;journal=Psychol%20Med&amp;volume=44&amp;issue=10&amp;pages=2099-2112&amp;publication_year=2014&amp;author=Gratz%2CKL&amp;author=Tull%2CMT&amp;author=Levy%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=25.><p class=c-article-references__text id=ref-CR25>Blum N, St. John D, Pfohl B, Stuart S, McCormick B, Allen J, Arndt S, Black DW. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for Outpatients With Borderline Personality Disorder: A Randomized Controlled Trial and 1-Year Follow-Up. Am J Psychiatr. 2008;165:468–78.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18281407" aria-label="PubMed reference 25">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1176%2Fappi.ajp.2007.07071079 aria-label="Article reference 25">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Systems%20Training%20for%20Emotional%20Predictability%20and%20Problem%20Solving%20%28STEPPS%29%20for%20Outpatients%20With%20Borderline%20Personality%20Disorder%3A%20A%20Randomized%20Controlled%20Trial%20and%201-Year%20Follow-Up&amp;journal=Am%20J%20Psychiatr&amp;volume=165&amp;pages=468-478&amp;publication_year=2008&amp;author=Blum%2CN&amp;author=St.%20John%2CD&amp;author=Pfohl%2CB&amp;author=Stuart%2CS&amp;author=McCormick%2CB&amp;author=Allen%2CJ&amp;author=Arndt%2CS&amp;author=Black%2CDW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=26.><p class=c-article-references__text id=ref-CR26>Bos EH, van Wel EB, Appelo MT, Verbraak MJ. A randomized controlled trial of a Dutch version of systems training for emotional predictability and problem solving for borderline personality disorder. J Nerv Ment Dis. 2010;198(4):299–304.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20386260" aria-label="PubMed reference 26">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1097%2FNMD.0b013e3181d619cf aria-label="Article reference 26">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20randomized%20controlled%20trial%20of%20a%20Dutch%20version%20of%20systems%20training%20for%20emotional%20predictability%20and%20problem%20solving%20for%20borderline%20personality%20disorder&amp;journal=J%20Nerv%20Ment%20Dis&amp;volume=198&amp;issue=4&amp;pages=299-304&amp;publication_year=2010&amp;author=Bos%2CEH&amp;author=Wel%2CEB&amp;author=Appelo%2CMT&amp;author=Verbraak%2CMJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=27.><p class=c-article-references__text id=ref-CR27>McMain SF, et al. A randomized trial of brief dialectical behaviour therapy skills training in suicidal patients suffering from borderline disorder. Acta Psychiatr Scand. 2017;135(2):138–48.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27858962" aria-label="PubMed reference 27">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1111%2Facps.12664 aria-label="Article reference 27">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20randomized%20trial%20of%20brief%20dialectical%20behaviour%20therapy%20skills%20training%20in%20suicidal%20patients%20suffering%20from%20borderline%20disorder&amp;journal=Acta%20Psychiatr%20Scand&amp;volume=135&amp;issue=2&amp;pages=138-148&amp;publication_year=2017&amp;author=McMain%2CSF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=28.><p class=c-article-references__text id=ref-CR28>McMain SF. Advances in the Treatment of Borderline Personality Disorder: An Introduction to the Special Issue. J Clin Psychol. 2015;71(8):741–6.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26239080" aria-label="PubMed reference 28">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1002%2Fjclp.22201 aria-label="Article reference 28">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Advances%20in%20the%20Treatment%20of%20Borderline%20Personality%20Disorder%3A%20An%20Introduction%20to%20the%20Special%20Issue&amp;journal=J%20Clin%20Psychol&amp;volume=71&amp;issue=8&amp;pages=741-746&amp;publication_year=2015&amp;author=McMain%2CSF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=29.><p class=c-article-references__text id=ref-CR29>Knekt P, et al. Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up. Psychol Med. 2008;38(5):689–703.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DC%2BD1czitFahsA%3D%3D aria-label="CAS reference 29">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18005493" aria-label="PubMed reference 29">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1017%2FS003329170700164X aria-label="Article reference 29">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Randomized%20trial%20on%20the%20effectiveness%20of%20long-and%20short-term%20psychodynamic%20psychotherapy%20and%20solution-focused%20therapy%20on%20psychiatric%20symptoms%20during%20a%203-year%20follow-up&amp;journal=Psychol%20Med&amp;volume=38&amp;issue=5&amp;pages=689-703&amp;publication_year=2008&amp;author=Knekt%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=30.><p class=c-article-references__text id=ref-CR30>Lorentzen S, et al. Comparison of short- and long-term dynamic group psychotherapy: randomised clinical trial. Br J Psychiatry. 2013;203(3):280–7.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24029539" aria-label="PubMed reference 30">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1192%2Fbjp.bp.112.113688 aria-label="Article reference 30">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=Comparison%20of%20short-%20and%20long-term%20dynamic%20group%20psychotherapy%3A%20randomised%20clinical%20trial&amp;journal=Br%20J%20Psychiatry&amp;volume=203&amp;issue=3&amp;pages=280-287&amp;publication_year=2013&amp;author=Lorentzen%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=31.><p class=c-article-references__text id=ref-CR31>Boutron I, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295–309.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18283207" aria-label="PubMed reference 31">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.7326%2F0003-4819-148-4-200802190-00008 aria-label="Article reference 31">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Extending%20the%20CONSORT%20statement%20to%20randomized%20trials%20of%20nonpharmacologic%20treatment%3A%20explanation%20and%20elaboration&amp;journal=Ann%20Intern%20Med&amp;volume=148&amp;issue=4&amp;pages=295-309&amp;publication_year=2008&amp;author=Boutron%2CI">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=32.><p class=c-article-references__text id=ref-CR32>Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol. 2001;1:2.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DC%2BD3srgs1ejug%3D%3D aria-label="CAS reference 32">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11336663" aria-label="PubMed reference 32">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC32201 aria-label="PubMed Central reference 32">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2F1471-2288-1-2 aria-label="Article reference 32">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20CONSORT%20statement%3A%20revised%20recommendations%20for%20improving%20the%20quality%20of%20reports%20of%20parallel%20group%20randomized%20trials&amp;journal=BMC%20Med%20Res%20Methodol&amp;volume=1&amp;publication_year=2001&amp;author=Moher%2CD&amp;author=Schulz%2CKF&amp;author=Altman%2CDG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=33.><p class=c-article-references__text id=ref-CR33>Chan A, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Ann Intern Med. 2013;158:200–7.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23295957" aria-label="PubMed reference 33">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114123 aria-label="PubMed Central reference 33">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.7326%2F0003-4819-158-3-201302050-00583 aria-label="Article reference 33">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=SPIRIT%202013%20Statement%3A%20Defining%20Standard%20Protocol%20Items%20for%20Clinical%20Trials&amp;journal=Ann%20Intern%20Med&amp;volume=158&amp;pages=200-207&amp;publication_year=2013&amp;author=Chan%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=34.><p class=c-article-references__text id=ref-CR34>Simonsen S, Heinskou T, Sørensen P, Folke S, Lau ME. Personality disorders: patient characteristics and level of outpatient treatment service. Nord J Psychiatry. 2017;71(5):325–31.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=35.><p class=c-article-references__text id=ref-CR35>Clifton A, Pilkonis PA. Evidence for a single latent class of Diagnostic and Statistical Manual of Mental Disorders borderline personality pathology. Compr Psychiatry. 2007;48(1):70–8.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17145285" aria-label="PubMed reference 35">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.comppsych.2006.07.002 aria-label="Article reference 35">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Evidence%20for%20a%20single%20latent%20class%20of%20Diagnostic%20and%20Statistical%20Manual%20of%20Mental%20Disorders%20borderline%20personality%20pathology&amp;journal=Compr%20Psychiatry&amp;volume=48&amp;issue=1&amp;pages=70-78&amp;publication_year=2007&amp;author=Clifton%2CA&amp;author=Pilkonis%2CPA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=36.><p class=c-article-references__text id=ref-CR36>Tyrer P, Reed GM, Crawford MJ. Classification, assessment, prevalence, and effect of personality disorder. Lancet. 2015;385(9969):717–26.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25706217" aria-label="PubMed reference 36">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS0140-6736%2814%2961995-4 aria-label="Article reference 36">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Classification%2C%20assessment%2C%20prevalence%2C%20and%20effect%20of%20personality%20disorder&amp;journal=Lancet&amp;volume=385&amp;issue=9969&amp;pages=717-726&amp;publication_year=2015&amp;author=Tyrer%2CP&amp;author=Reed%2CGM&amp;author=Crawford%2CMJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=37.><p class=c-article-references__text id=ref-CR37>Beck E, et al. Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial. Trials. 2016;17(1):314.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27405522" aria-label="PubMed reference 37">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942923 aria-label="PubMed Central reference 37">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2Fs13063-016-1431-0 aria-label="Article reference 37">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Mentalization-based%20treatment%20in%20groups%20for%20adolescents%20with%20borderline%20personality%20disorder%20%28BPD%29%20or%20subthreshold%20BPD%20versus%20treatment%20as%20usual%20%28M-GAB%29%3A%20study%20protocol%20for%20a%20randomized%20controlled%20trial&amp;journal=Trials&amp;volume=17&amp;issue=1&amp;publication_year=2016&amp;author=Beck%2CE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=38.><p class=c-article-references__text id=ref-CR38>Zanarini. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Personal Disord. 2003;17(3):233–42.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1521%2Fpedi.17.3.233.22147 aria-label="Article reference 38">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Zanarini%20Rating%20Scale%20for%20Borderline%20Personality%20Disorder%20%28ZAN-BPD%29%3A%20a%20continuous%20measure%20of%20DSM-IV%20borderline%20psychopathology&amp;journal=J%20Personal%20Disord&amp;volume=17&amp;issue=3&amp;pages=233-242&amp;publication_year=2003&amp;author=Zanarini%2C">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=39.><p class=c-article-references__text id=ref-CR39>National Insitute for Health and Care Excellence (NICE). Borderline Personality Disorder: the NICE Guideline on Treatment and Management. Br Psychol Soc R Coll Psychiatrists. 2009.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=40.><p class=c-article-references__text id=ref-CR40>Karterud S, Bateman A. Manual for mentaliseringsbasert psykoedukativ gruppeterapi (MBT-I). Oslo: Gyldendal akademisk; 2011.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=41.><p class=c-article-references__text id=ref-CR41>Sundhedsstyrelsen, National klinisk retningslinje for behandling af emotionel ustabil personlighedsstruktur, borderline type. 2015.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=National%20klinisk%20retningslinje%20for%20behandling%20af%20emotionel%20ustabil%20personlighedsstruktur%2C%20borderline%20type&amp;publication_year=2015">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=42.><p class=c-article-references__text id=ref-CR42>Lecrubier Y, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry. 1997;12:224–31.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2FS0924-9338%2897%2983296-8 aria-label="Article reference 42">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20Mini%20International%20Neuropsychiatric%20Interview%20%28MINI%29.%20A%20short%20diagnostic%20structured%20interview%3A%20reliability%20and%20validity%20according%20to%20the%20CIDI&amp;journal=Eur%20Psychiatry&amp;volume=12&amp;pages=224-231&amp;publication_year=1997&amp;author=Lecrubier%2CY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=43.><p class=c-article-references__text id=ref-CR43>First MB, et al. The Structured Clinical Interview for DSM-II-R Personality Disorders (SCID-II). Part II: Multi-site test-retest reliability study. J Personal Disord. 1995;9(2):92–104.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1521%2Fpedi.1995.9.2.92 aria-label="Article reference 43">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20Structured%20Clinical%20Interview%20for%20DSM-II-R%20Personality%20Disorders%20%28SCID-II%29.%20Part%20II%3A%20Multi-site%20test-retest%20reliability%20study&amp;journal=J%20Personal%20Disord&amp;volume=9&amp;issue=2&amp;pages=92-104&amp;publication_year=1995&amp;author=First%2CMB">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=44.><p class=c-article-references__text id=ref-CR44>Lobbestael J, Leurgans M, Arntz A. Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II). Clin Psychol Psychother. 2011;18(1):75–9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20309842" aria-label="PubMed reference 44">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1002%2Fcpp.693 aria-label="Article reference 44">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=Inter-rater%20reliability%20of%20the%20Structured%20Clinical%20Interview%20for%20DSM-IV%20Axis%20I%20Disorders%20%28SCID%20I%29%20and%20Axis%20II%20Disorders%20%28SCID%20II%29&amp;journal=Clin%20Psychol%20Psychother&amp;volume=18&amp;issue=1&amp;pages=75-79&amp;publication_year=2011&amp;author=Lobbestael%2CJ&amp;author=Leurgans%2CM&amp;author=Arntz%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=45.><p class=c-article-references__text id=ref-CR45>Cicchetti DV. Guidelines, Criteria, an Rules of Thumb for Evaluating Normed and Standardized Assessment Instruments in Psychology. Psychol Assess. 1994;6(4):284–90.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1037%2F1040-3590.6.4.284 aria-label="Article reference 45">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=Guidelines%2C%20Criteria%2C%20an%20Rules%20of%20Thumb%20for%20Evaluating%20Normed%20and%20Standardized%20Assessment%20Instruments%20in%20Psychology&amp;journal=Psychol%20Assess&amp;volume=6&amp;issue=4&amp;pages=284-290&amp;publication_year=1994&amp;author=Cicchetti%2CDV">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=46.><p class=c-article-references__text id=ref-CR46>Pedersen G, Kvarstein EH, Wilberg T. The Work and Social Adjustment Scale: Psychometric properties and validity among males and females, and outpatients with and without personality disorders. Personal Ment Health. 2017;11(4):215–28.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DC%2BC1cjkvFGguw%3D%3D aria-label="CAS reference 46">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28681505" aria-label="PubMed reference 46">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1002%2Fpmh.1382 aria-label="Article reference 46">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20Work%20and%20Social%20Adjustment%20Scale%3A%20Psychometric%20properties%20and%20validity%20among%20males%20and%20females%2C%20and%20outpatients%20with%20and%20without%20personality%20disorders&amp;journal=Personal%20Ment%20Health&amp;volume=11&amp;issue=4&amp;pages=215-228&amp;publication_year=2017&amp;author=Pedersen%2CG&amp;author=Kvarstein%2CEH&amp;author=Wilberg%2CT">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=47.><p class=c-article-references__text id=ref-CR47>Miles HH, Barrabee EL, Finesinger JE. Evaluation of psychotherapy: with a follow up study of 62 cases of anxiety neurosis. Psychosom Med. 1951 Mar-Apr;13(2):83-105.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=48.><p class=c-article-references__text id=ref-CR48>Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection. Med Care. 1992;30(6):473–83.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1593914" aria-label="PubMed reference 48">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1097%2F00005650-199206000-00002 aria-label="Article reference 48">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20MOS%2036-Item%20Short-Form%20Health%20Survey%20%28SF-36%29%3A%20I.%20Conceptual%20Framework%20and%20Item%20Selection&amp;journal=Med%20Care&amp;volume=30&amp;issue=6&amp;pages=473-483&amp;publication_year=1992&amp;author=Ware%2CJE&amp;author=Sherbourne%2CCD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=49.><p class=c-article-references__text id=ref-CR49>Jones SH, et al. Reliability and Validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 1995;166:654–9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DyaK2Mzks1Wmtw%3D%3D aria-label="CAS reference 49">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7620753" aria-label="PubMed reference 49">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1192%2Fbjp.166.5.654 aria-label="Article reference 49">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=Reliability%20and%20Validity%20of%20the%20Global%20Assessment%20of%20Functioning%20%28GAF%29&amp;journal=Br%20J%20Psychiatry&amp;volume=166&amp;pages=654-659&amp;publication_year=1995&amp;author=Jones%2CSH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=50.><p class=c-article-references__text id=ref-CR50>Derogatis LR, Cleary PA. Confirmation of the dimensional structure of the SCL-90: a study in construct validation. J Clin Psychol. 1977;33(4):981–9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1002%2F1097-4679%28197710%2933%3A4%3C981%3A%3AAID-JCLP2270330412%3E3.0.CO%3B2-0 aria-label="Article reference 50">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=Confirmation%20of%20the%20dimensional%20structure%20of%20the%20SCL-90%3A%20a%20study%20in%20construct%20validation&amp;journal=J%20Clin%20Psychol&amp;volume=33&amp;issue=4&amp;pages=981-989&amp;publication_year=1977&amp;author=Derogatis%2CLR&amp;author=Cleary%2CPA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=51.><p class=c-article-references__text id=ref-CR51>Hutsebaut J, Feensta D, Kamphuis J. Development and Preliminary Psychometric Evaluation of a Brief Self-Report Questionnaire for the Assessment of the DSM–5 Level of Personality Functioning Scale: The LPFS Brief Form (LPFS-BF). Personal Disord Theory Res Treat. 2016;7(2):192–4.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1037%2Fper0000159 aria-label="Article reference 51">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;title=Development%20and%20Preliminary%20Psychometric%20Evaluation%20of%20a%20Brief%20Self-Report%20Questionnaire%20for%20the%20Assessment%20of%20the%20DSM%E2%80%935%20Level%20of%20Personality%20Functioning%20Scale%3A%20The%20LPFS%20Brief%20Form%20%28LPFS-BF%29&amp;journal=Personal%20Disord%20Theory%20Res%20Treat&amp;volume=7&amp;issue=2&amp;pages=192-194&amp;publication_year=2016&amp;author=Hutsebaut%2CJ&amp;author=Feensta%2CD&amp;author=Kamphuis%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=52.><p class=c-article-references__text id=ref-CR52>Bartholomew K, Horowitz LM. Attachment Styles Among Young Adults: A Test of a Four-Category Model. J Pers Soc Psychol. 1991;61(2):226–44.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DyaK38%2FhsVOgtQ%3D%3D aria-label="CAS reference 52">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1920064" aria-label="PubMed reference 52">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1037%2F0022-3514.61.2.226 aria-label="Article reference 52">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;title=Attachment%20Styles%20Among%20Young%20Adults%3A%20A%20Test%20of%20a%20Four-Category%20Model&amp;journal=J%20Pers%20Soc%20Psychol&amp;volume=61&amp;issue=2&amp;pages=226-244&amp;publication_year=1991&amp;author=Bartholomew%2CK&amp;author=Horowitz%2CLM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=53.><p class=c-article-references__text id=ref-CR53>Zanarini, et al. Development of the self-report version of the Zanarini Rating Scale for Borderline Personality Disorder. Personal Ment Health. 2015;9(4):243–9.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26174588" aria-label="PubMed reference 53">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609276 aria-label="PubMed Central reference 53">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1002%2Fpmh.1302 aria-label="Article reference 53">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;title=Development%20of%20the%20self-report%20version%20of%20the%20Zanarini%20Rating%20Scale%20for%20Borderline%20Personality%20Disorder&amp;journal=Personal%20Ment%20Health&amp;volume=9&amp;issue=4&amp;pages=243-249&amp;publication_year=2015&amp;author=Zanarini%2C">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=54.><p class=c-article-references__text id=ref-CR54>Krogel J, et al. The Group Questionnaire: a clinical and empirically derived measure of group relationship. Psychother Res. 2013;23(3):344–54.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23432457" aria-label="PubMed reference 54">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1080%2F10503307.2012.729868 aria-label="Article reference 54">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20Group%20Questionnaire%3A%20a%20clinical%20and%20empirically%20derived%20measure%20of%20group%20relationship&amp;journal=Psychother%20Res&amp;volume=23&amp;issue=3&amp;pages=344-354&amp;publication_year=2013&amp;author=Krogel%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=55.><p class=c-article-references__text id=ref-CR55>Hausberg M, Schulz H, Piegler T, Happach C, Klöpper M, Brütt A, et al. Is a self-rated instrument appropriate to assess mentalization in patients with mental disorders? Development and first validation of the Mentalization Questionnaire (MZQ). Psychother Res. 2012;22(6):699–709.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22867004" aria-label="PubMed reference 55">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1080%2F10503307.2012.709325 aria-label="Article reference 55">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;title=Is%20a%20self-rated%20instrument%20appropriate%20to%20assess%20mentalization%20in%20patients%20with%20mental%20disorders%3F%20Development%20and%20first%20validation%20of%20the%20Mentalization%20Questionnaire%20%28MZQ%29&amp;journal=Psychother%20Res&amp;volume=22&amp;issue=6&amp;pages=699-709&amp;publication_year=2012&amp;author=Hausberg%2CM&amp;author=Schulz%2CH&amp;author=Piegler%2CT&amp;author=Happach%2CC&amp;author=Kl%C3%B6pper%2CM&amp;author=Br%C3%BCtt%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=56.><p class=c-article-references__text id=ref-CR56>Gotzsche PC. Blinding during data analysis and writing of manuscripts. Control Clin Trials. 1996;17(4):285–90 discussion 290-3.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://link.springer.com/articles/cas-redirect/1:STN:280:DyaK2s%2FksVaksA%3D%3D aria-label="CAS reference 56">CAS</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8889343" aria-label="PubMed reference 56">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2F0197-2456%2895%2900263-4 aria-label="Article reference 56">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;title=Blinding%20during%20data%20analysis%20and%20writing%20of%20manuscripts&amp;journal=Control%20Clin%20Trials&amp;volume=17&amp;issue=4&amp;pages=285-290&amp;publication_year=1996&amp;author=Gotzsche%2CPC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=57.><p class=c-article-references__text id=ref-CR57>Jarvinen TL, et al. Blinded interpretation of study results can feasibly and effectively diminish interpretation bias. J Clin Epidemiol. 2014;67(7):769–72.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24560088" aria-label="PubMed reference 57">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1016%2Fj.jclinepi.2013.11.011 aria-label="Article reference 57">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;title=Blinded%20interpretation%20of%20study%20results%20can%20feasibly%20and%20effectively%20diminish%20interpretation%20bias&amp;journal=J%20Clin%20Epidemiol&amp;volume=67&amp;issue=7&amp;pages=769-772&amp;publication_year=2014&amp;author=Jarvinen%2CTL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=58.><p class=c-article-references__text id=ref-CR58>Priebe S, et al. Effectiveness and cost-effectiveness of dialectical behaviour therapy for self-harming patients with personality disorder: a pragmatic randomised controlled trial. Psychother Psychosom. 2012;81(6):356–65.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22964561" aria-label="PubMed reference 58">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1159%2F000338897 aria-label="Article reference 58">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;title=Effectiveness%20and%20cost-effectiveness%20of%20dialectical%20behaviour%20therapy%20for%20self-harming%20patients%20with%20personality%20disorder%3A%20a%20pragmatic%20randomised%20controlled%20trial&amp;journal=Psychother%20Psychosom&amp;volume=81&amp;issue=6&amp;pages=356-365&amp;publication_year=2012&amp;author=Priebe%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=59.><p class=c-article-references__text id=ref-CR59>Jakobsen JC, et al. The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol. 2014;14:34.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24588900" aria-label="PubMed reference 59">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015863 aria-label="PubMed Central reference 59">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2F1471-2288-14-34 aria-label="Article reference 59">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20thresholds%20for%20statistical%20and%20clinical%20significance%20-%20a%20five-step%20procedure%20for%20evaluation%20of%20intervention%20effects%20in%20randomised%20clinical%20trials&amp;journal=BMC%20Med%20Res%20Methodol&amp;volume=14&amp;publication_year=2014&amp;author=Jakobsen%2CJC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=60.><p class=c-article-references__text id=ref-CR60>Jakobsen JC, et al. When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29207961" aria-label="PubMed reference 60">PubMed</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717805 aria-label="PubMed Central reference 60">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" href=https://doi.org/10.1186%2Fs12874-017-0442-1 aria-label="Article reference 60">Article</a>&nbsp;
 <a data-track=click data-track-action="outbound reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 60" href="http://scholar.google.com/scholar_lookup?&amp;title=When%20and%20how%20should%20multiple%20imputation%20be%20used%20for%20handling%20missing%20data%20in%20randomised%20clinical%20trials%20-%20a%20practical%20guide%20with%20flowcharts&amp;journal=BMC%20Med%20Res%20Methodol&amp;volume=17&amp;issue=1&amp;publication_year=2017&amp;author=Jakobsen%2CJC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=61.><p class=c-article-references__text id=ref-CR61>Englev E, Petersen KP. ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives. Dan Med J. 2003;165(16):1659–62.</p></ol><p class="c-article-references__download u-hide-print"><a data-track=click data-track-action="download citation references" data-track-label=link href="https://citation-needed.springer.com/v2/references/10.1186/s13063-019-3306-7?format=refman&amp;flavour=references">Download references<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a></p></div></div></div></section></div><section data-title=Acknowledgements><div class=c-article-section id=Ack1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Ack1>Acknowledgements</h2><div class=c-article-section__content id=Ack1-content><p>We are grateful to the participants and to our colleagues at the Outpatient Clinic for Personality Disorders at Stolpegaard Psychotherapy Centre for their hard work and good cooperation.</p>
 <h3 class=c-article__sub-heading id=FPar1>Funding</h3>
 <p>The trial is funded by research grants from TrygFonden and from the Mental Health Services Research Foundation, Capital Region of Denmark. Funding applications have undergone anonymous peer review. Neither the funding bodies nor the sponsor will be involved in the collection, analysis, or interpretation of the data, or in writing the manuscripts. The grants will be administered by the head of administration at Stolpegaard Psychotherapy Center. At the end of the trial, the budget will undergo external auditing independently of the trial sponsor and investigators.</p>
 
 <h3 class=c-article__sub-heading id=FPar2>Availability of data and materials</h3>
 <p>The trial investigators, the steering committee, and statisticians at the Copenhagen Trial Unit will have access to the data. After the end of the trial, approval for making the final dataset publicly available in a depersonalized format in the Danish Data Archive will be applied for through the Danish Data Protection Agency.</p>
 
 <h3 class=c-article__sub-heading id=FPar3>Trial sponsor</h3>
 <p>The sponsor of the trial is the Mental Health Services in the Capital Region of Denmark, Kristineberg 3, 2100 Copenhagen Ø.</p>
 
 <h3 class=c-article__sub-heading id=FPar4>Protocol amendments</h3>
 <p>No substantial deviations from the protocol will be implemented without the prior review and approval of the regulatory authorities, except where such may be necessary to eliminate an immediate hazard to the trial participants. In such case, the deviation will be reported to the regulatory authorities as soon as possible. Any deviation, however minor, will be documented and made available in the trial master file in a designated table developed for this purpose.</p>
 </div></div></section><section aria-labelledby=author-information data-title="Author information"><div class=c-article-section id=author-information-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=author-information>Author information</h2><div class=c-article-section__content id=author-information-content><h3 class=c-article__sub-heading id=affiliations>Authors and Affiliations</h3><ol class=c-article-author-affiliation__list><li id=Aff1><p class=c-article-author-affiliation__address>Stolpegaard Psychotherapy Centre, Mental Health Services, Gentofte, Capital Region of Denmark, Denmark<p class=c-article-author-affiliation__authors-list>Sophie Juul,&nbsp;Per Sørensen,&nbsp;Mehrak Salimi&nbsp;&amp;&nbsp;Sebastian Simonsen</p><li id=Aff2><p class=c-article-author-affiliation__address>Department of Psychology, University of Copenhagen, Copenhagen, Denmark<p class=c-article-author-affiliation__authors-list>Sophie Juul,&nbsp;Susanne Lunn&nbsp;&amp;&nbsp;Stig Poulsen</p><li id=Aff3><p class=c-article-author-affiliation__address>Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark<p class=c-article-author-affiliation__authors-list>Janus Christian Jakobsen</p><li id=Aff4><p class=c-article-author-affiliation__address>St. Anns Hospital, London, England<p class=c-article-author-affiliation__authors-list>Anthony Bateman</p></ol><div class="u-js-hide u-hide-print sf-hidden" data-test=author-info></div><h3 class=c-article__sub-heading id=contributions>Contributions</h3><p>SS and SJ conceived the initial idea of a randomized controlled trial comparing short-term and long-term MBT for borderline personality disorder, along with MS, the acting chief psychologist at the clinic. PS approved of the idea and provided organizational support. SS and SJ developed the trial design with contributions and supervision from JCJ, SL, SP, PS, and AB. SJ wrote the protocol, which was carefully discussed with SS, JCJ, SL, SP, PS, and AB. JCJ designed the plan for the statistical analyses and wrote the sections on sample size and statistical approach. All authors read and approved the final manuscript.<h3 class=c-article__sub-heading id=corresponding-author>Corresponding author</h3><p id=corresponding-author-list>Correspondence to
 <a id=corresp-c1 href=mailto:sophie.juul@regionh.dk>Sophie Juul</a>.</p></div></div></section><section data-title="Ethics declarations"><div class=c-article-section id=ethics-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=ethics>Ethics declarations</h2><div class=c-article-section__content id=ethics-content>
 
 <h3 class=c-article__sub-heading id=FPar5>Ethics approval and consent to participate</h3>
 <p>There are no ethical concerns regarding this trial. Both the experimental intervention and control intervention follow the treatment guidelines published by the National Institute for Health and Care Excellence and the Danish Health and Medicines Authority. Any participants can, at any time, withdraw their consent without any implications for future treatment at the clinic. Prior to commencing the trial, ethical approval was obtained from the regional research ethics committee (ID number H-18023136) and approval was obtained from the Danish Data Protection Agency (I-suite number 6553). During the trial period, data on adverse events will be collected at four time points and will be reported to the regional research ethics committee.</p>
 
 
 <h3 class=c-article__sub-heading id=FPar6>Competing interests</h3>
 <p>The authors declare that they have no competing interests.</p>
 
 
 <h3 class=c-article__sub-heading id=FPar7>Publisher’s Note</h3>
 <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
 
 </div></div></section><section data-title="Additional file"><div class=c-article-section id=Sec27-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec27>Additional file</h2><div class=c-article-section__content id=Sec27-content><div data-test=supplementary-info><div id=figshareContainer class=c-article-figshare-container data-test=figshare-container></div>
 
 <div class=c-article-supplementary__item data-test=supp-item id=MOESM1><h3 class="c-article-supplementary__title u-h3"><a class=print-link data-track=click data-track-action="view supplementary info" data-track-label=link data-test=supp-info-link href=https://static-content.springer.com/esm/art%3A10.1186%2Fs13063-019-3306-7/MediaObjects/13063_2019_3306_MOESM1_ESM.docx data-supp-info-image>Additional file 1:</a></h3><div class=c-article-supplementary__description data-component=thumbnail-container><p>SPIRIT checklist. (DOCX 61 kb)</p></div></div></div></div></div></section><section data-title="Rights and permissions"><div class=c-article-section id=rightslink-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=rightslink>Rights and permissions</h2><div class=c-article-section__content id=rightslink-content>
 <p><b>Open Access</b> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<a href=http://creativecommons.org/licenses/by/4.0/ rel=license>http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<a href=http://creativecommons.org/publicdomain/zero/1.0/ rel=license>http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</p>
 <p class=c-article-rights><a data-track=click data-track-action="view rights and permissions" data-track-label=link href="https://s100.copyright.com/AppDispatchServlet?title=Short-term%20versus%20long-term%20mentalization-based%20therapy%20for%20outpatients%20with%20subthreshold%20or%20diagnosed%20borderline%20personality%20disorder%3A%20a%20protocol%20for%20a%20randomized%20clinical%20trial&amp;author=Sophie%20Juul%20et%20al&amp;contentID=10.1186%2Fs13063-019-3306-7&amp;copyright=The%20Author%28s%29.&amp;publication=1745-6215&amp;publicationDate=2019-04-05&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY%20%2B%20CC0">Reprints and Permissions</a></p></div></div></section><section aria-labelledby=article-info data-title="About this article"><div class=c-article-section id=article-info-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=article-info>About this article</h2><div class=c-article-section__content id=article-info-content><div class=c-bibliographic-information><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark=10.1186/s13063-019-3306-7 target=_blank rel=noopener href="https://crossmark.crossref.org/dialog/?doi=10.1186/s13063-019-3306-7" data-track=click data-track-action="Click Crossmark" data-track-label=link data-test=crossmark><img width=57 height=81 alt="Verify currency and authenticity via CrossMark" src=data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>></a></div><div class=c-bibliographic-information__column><h3 class=c-article__sub-heading id=citeas>Cite this article</h3><p class=c-bibliographic-information__citation>Juul, S., Lunn, S., Poulsen, S. <i>et al.</i> Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial.
 <i>Trials</i> <b>20, </b>196 (2019). https://doi.org/10.1186/s13063-019-3306-7<p class="c-bibliographic-information__download-citation u-hide-print"><a data-test=citation-link data-track=click data-track-action="download article citation" data-track-label=link data-track-external href="https://citation-needed.springer.com/v2/references/10.1186/s13063-019-3306-7?format=refman&amp;flavour=citation">Download citation<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a><ul class=c-bibliographic-information__list data-test=publication-history><li class=c-bibliographic-information__list-item><p>Received<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2018-10-11>11 October 2018</time></span></p><li class=c-bibliographic-information__list-item><p>Accepted<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2019-03-19>19 March 2019</time></span></p><li class=c-bibliographic-information__list-item><p>Published<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2019-04-05>05 April 2019</time></span></p><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value>https://doi.org/10.1186/s13063-019-3306-7</span></p></ul><div data-component=share-box><div class="c-article-share-box u-display-inline"><h3 class=c-article__sub-heading>Share this article</h3><p class=c-article-share-box__description>Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id=get-share-url data-track=click data-track-label=button data-track-external data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none sf-hidden" hidden></div><div class="js-share-url-container u-display-none sf-hidden" hidden></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
 Provided by the Springer Nature SharedIt content-sharing initiative
 </p></div></div><h3 class=c-article__sub-heading>Keywords</h3><ul class=c-article-subject-list><li class=c-article-subject-list__subject><span>Mentalization-based therapy</span><li class=c-article-subject-list__subject><span>Borderline personality disorder</span><li class=c-article-subject-list__subject><span>Randomized clinical trial</span><li class=c-article-subject-list__subject><span>Treatment intensity</span></ul><div data-component=article-info-list></div></div></div></div></div></section>
 </div>
 </article>
 </main>
 <div class="c-article-extras u-text-sm u-hide-print" id=sidebar data-container-type=reading-companion data-track-component="reading companion">
 <aside>
 
 <div data-test=download-article-link-wrapper class=js-context-bar-sticky-point-desktop>
 
 <div class=c-pdf-container>
 <div class="c-pdf-download u-clear-both">
 <a href=https://link.springer.com/content/pdf/10.1186/s13063-019-3306-7.pdf class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf=true data-readcube-pdf-url=true data-test=pdf-link data-draft-ignore=true data-track=click data-track-action="download pdf" data-track-label=button data-track-external>
 
 <span class=c-pdf-download__text>Download PDF</span>
 <svg aria-hidden=true focusable=false width=16 height=16 class=u-icon><use xlink:href=#global-icon-download></use></svg>
 
 </a>
 </div>
 </div>
 </div>
 <div data-test=collections>
 
 
 </div>
 <div data-test=editorial-summary>
 
 </div>
 <div class=c-reading-companion>
 <div class=c-reading-companion__sticky data-component=reading-companion-sticky data-test=reading-companion-sticky style=top:40px>
 
 <ul class=c-reading-companion__tabs role=tablist><li role=presentation><button data-tab-target=sections role=tab id=tab-sections aria-controls=tabpanel-sections aria-selected=true class="c-reading-companion__tab c-reading-companion__tab--active" data-track=click data-track-action="sections tab" data-track-label=tab>Sections</button><li role=presentation><button data-tab-target=figures role=tab id=tab-figures aria-controls=tabpanel-figures aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="figures tab" data-track-label=tab>Figures</button><li role=presentation><button data-tab-target=references role=tab id=tab-references aria-controls=tabpanel-references aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="references tab" data-track-label=tab>References</button></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id=tabpanel-sections aria-labelledby=tab-sections role=tabpanel><div class=c-reading-companion__scroll-pane style=max-height:29599.5px><ul class=c-reading-companion__sections-list><li id=rc-sec-Abs1 class="c-reading-companion__section-item c-reading-companion__section-item--active"><a href=#Abs1 data-track=click data-track-action="section anchor" data-track-label=link:Abstract>Abstract</a><li id=rc-sec-Sec1 class=c-reading-companion__section-item><a href=#Sec1 data-track=click data-track-action="section anchor" data-track-label=link:Background>Background</a><li id=rc-sec-Sec2 class=c-reading-companion__section-item><a href=#Sec2 data-track=click data-track-action="section anchor" data-track-label=link:Methodsdesign>Methods/design</a><li id=rc-sec-Sec24 class=c-reading-companion__section-item><a href=#Sec24 data-track=click data-track-action="section anchor" data-track-label=link:Discussion>Discussion</a><li id=rc-sec-abbreviations class=c-reading-companion__section-item><a href=#abbreviations data-track=click data-track-action="section anchor" data-track-label=link:Abbreviations>Abbreviations</a><li id=rc-sec-Bib1 class=c-reading-companion__section-item><a href=#Bib1 data-track=click data-track-action="section anchor" data-track-label=link:References>References</a><li id=rc-sec-Ack1 class=c-reading-companion__section-item><a href=#Ack1 data-track=click data-track-action="section anchor" data-track-label=link:Acknowledgements>Acknowledgements</a><li id=rc-sec-author-information class=c-reading-companion__section-item><a href=#author-information data-track=click data-track-action="section anchor" data-track-label="link:Author information">Author information</a><li id=rc-sec-ethics class=c-reading-companion__section-item><a href=#ethics data-track=click data-track-action="section anchor" data-track-label="link:Ethics declarations">Ethics declarations</a><li id=rc-sec-Sec27 class=c-reading-companion__section-item><a href=#Sec27 data-track=click data-track-action="section anchor" data-track-label="link:Additional file">Additional file</a><li id=rc-sec-rightslink class=c-reading-companion__section-item><a href=#rightslink data-track=click data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a><li id=rc-sec-article-info class=c-reading-companion__section-item><a href=#article-info data-track=click data-track-action="section anchor" data-track-label="link:About this article">About this article</a></ul></div>
 <div class=u-mt-16 data-component-mpu>
 <aside class="c-ad c-ad--300x250 sf-hidden">
 
 </aside>
</div>
 </div>
 <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width sf-hidden" id=tabpanel-figures aria-labelledby=tab-figures role=tabpanel><div class="c-reading-companion__scroll-pane sf-hidden"><ul class="c-reading-companion__figures-list sf-hidden"><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3306-7/MediaObjects/13063_2019_3306_Fig1_HTML.png?as=webp"></picture></figure><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3306-7/MediaObjects/13063_2019_3306_Fig2_HTML.png?as=webp"></picture></figure></ul></div></div>
 <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width sf-hidden" id=tabpanel-references aria-labelledby=tab-references role=tabpanel></div>
 </div>
 </div>
 </aside>
 </div>
 </div>
 
 
 
 
 
 
 <footer class=app-footer role=contentinfo data-test=springerlink-footer>
 <div class="app-footer__aside-wrapper u-hide-print">
 <div class=app-footer__container>
 <p class=app-footer__strapline>Over 10 million scientific documents at your fingertips</p>
 
 <div class=app-footer__edition data-component=SV.EditionSwitcher>
 <span class=u-visually-hidden data-role=button-dropdown__title data-btn-text="Switch between Academic &amp; Corporate Edition">Switch Edition</span>
 <ul class=app-footer-edition-list data-role=button-dropdown__content data-test=footer-edition-switcher-list>
 <li class=selected>
 <a data-test=footer-academic-link href=https://link.springer.com/siteEdition/link id=siteedition-academic-link>Academic Edition</a>
 </li>
 <li>
 <a data-test=footer-corporate-link href=https://link.springer.com/siteEdition/rd id=siteedition-corporate-link>Corporate Edition</a>
 </li>
 </ul>
 </div>
 
 </div>
 </div>
 <div class=app-footer__container>
 <ul class="app-footer__nav u-hide-print">
 <li><a href=https://link.springer.com/>Home</a></li>
 <li><a href=https://link.springer.com/impressum>Impressum</a></li>
 <li><a href=https://link.springer.com/termsandconditions>Legal information</a></li>
 <li><a href=https://link.springer.com/privacystatement>Privacy statement</a></li>
 <li><a href=https://www.springernature.com/ccpa>California Privacy Statement</a></li>
 <li><a href=https://link.springer.com/cookiepolicy>How we use cookies</a></li>
 
 <li><a class=optanon-toggle-display data-cc-action=preferences href=https://link.springer.com/article/10.1186/s13063-019-3306-7>Manage cookies/Do not sell my data</a></li>
 
 <li><a href=https://link.springer.com/accessibility>Accessibility</a></li>
 <li><a href=https://support.springer.com/en/support/home>FAQ</a></li>
 <li><a id=contactus-footer-link href=https://support.springer.com/en/support/solutions/articles/6000206179-contacting-us>Contact us</a></li>
 <li><a href=https://www.springer.com/gp/shop/promo/affiliate/springer-nature>Affiliate program</a></li>
 </ul>
 <div class=c-user-metadata>
 
 <p class=c-user-metadata__item>
 <span data-test=footer-user-login-status>Not logged in</span>
 <span data-test=footer-user-ip> - 128.76.247.226</span>
 </p>
 <p class=c-user-metadata__item data-test=footer-business-partners>
 1236 DEFF LNCS (3000236495) - DEFF Consortium Danish National Library Authority (2000421697) - Royal Danish Library National License Consortium (2000599766) - DEFF Danish Agency for Culture (3000209025) - Royal Danish Library att: Lone Katberg (3004089649) 
 </p>
 
</div>
 <a class=app-footer__parent-logo target=_blank rel=noopener href=https://www.springernature.com/ title="Go to Springer Nature">
 <span class=u-visually-hidden>Springer Nature</span>
 <svg width=125 height=12 focusable=false aria-hidden=true>
 <image width=125 height=12 alt="Springer Nature logo" src=/oscar-static/images/springerlink/png/springernature-60a72a849b.png xmlns:xlink=http://www.w3.org/1999/xlink xlink:href="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAxMjUgMTIiPjx0aXRsZT5TcHJpbmdlck5hdHVyZTwvdGl0bGU+PHBhdGggZD0iTTY2LjgzIDQuN2MwLTIuNDgtMi4xMi0zLjM2LTQuMS0zLjM2aC0zLjQxdjEwLjNoMi41N3YtMy4xMWgxLjI0YTcuODYgNy44NiAwIDAgMSAxLjE1IDMuMTRoMi44MWExMS40OCAxMS40OCAwIDAgMC0xLjYtNCAzLjY4IDMuNjggMCAwIDAgMS4zMy0zem0tMi43Mi4zNmExLjI5IDEuMjkgMCAwIDEtMS40NiAxLjUzIDYuMzYgNi4zNiAwIDAgMS0uNzMgMHYtMy4yOWguNzZjMS4xOSAwIDEuNDIuNjggMS40MiAxLjc4em0tNi42OCA2LjZ2LTJoLTMuN3YtMi4yN2gzLjMzdi0yaC0zLjMzdi0yaDMuNjR2LTJoLTYuMXY4LjQ1YTIuMTEgMi4xMSAwIDAgMCAuNTIgMS4zNyAxLjkgMS45IDAgMCAwIDEuNDIuNTNjMS44NiAwIDMuOTEtLjA2IDQuMi0uMDd6bS0xMS41Mi4zNGE4LjY4IDguNjggMCAwIDAgMy42Mi0uODR2LTUuMTZoLTMuMzl2MS43OGgxLjA3djIuMWE0LjY2IDQuNjYgMCAwIDEtMS4xMy4xNGMtMS4zNiAwLTEuODktMS0xLjg5LTMuNTcgMC0yLjI1Ljc4LTMuMzQgMi4zOS0zLjM0YTUuNDggNS40OCAwIDAgMSAyLjE1LjY2bC42Ny0xLjdhNi40NCA2LjQ0IDAgMCAwLTMuMjUtLjkzIDQuMiA0LjIgMCAwIDAtMy40MyAxLjMzIDYuMTEgNi4xMSAwIDAgMC0xLjEyIDRjMCA0IDEuMTcgNS40OCA0LjMgNS40OHptLTguNjYtLjMyaDIuNzV2LTEwLjMzaC0yLjMydjYuNzVsLTMuMDgtNi43NWgtMi44MXYxMC4zMWgyLjI2di02LjVsMy4xOSA2LjV6bS0xMC4yNS0uMDJoMi41N3YtMTAuMjloLTIuNTd2MTAuMjl6bS0zLjIyLTRhMy42NyAzLjY3IDAgMCAwIDEuMzMtM2MwLTIuNDctMi4xMi0zLjM1LTQuMS0zLjM1aC0zLjQxdjEwLjNoMi41N3YtMy4wOGgxLjIyYTcuODUgNy44NSAwIDAgMSAxLjE0IDMuMTRoMi44MWExMS40MyAxMS40MyAwIDAgMC0xLjU5LTR6bS0xLjQyLTIuNmExLjMgMS4zIDAgMCAxLTEuNDYgMS41NGgtLjczdi0zLjNoLjc2YzEuMTkgMCAxLjQzLjY4IDEuNDMgMS43OHYtLjAyem0tNi4wOC0uNGMwLTIuMTQtMS4zNi0zLjMyLTMuODItMy4zMmgtMy40MXYxMC4zaDIuNTV2LTMuMTFoLjc4YTMuNTYgMy41NiAwIDAgMCAzLjg5LTMuODZ6bS0yLjQ1LjRhMS4yOSAxLjI5IDAgMCAxLTEuNDYgMS41MyA2LjM2IDYuMzYgMCAwIDEtLjczIDB2LTMuMjloLjc2YzEuMTkgMCAxLjQyLjY4IDEuNDIgMS43OHptLTEwLjgzLTEuNzNhMS4xMyAxLjEzIDAgMCAxIDEuMDg4LTEuMTdoLjA5MmE1LjU0IDUuNTQgMCAwIDEgMi4yNi42NGwuOTQtMS44NmE2LjU0IDYuNTQgMCAwIDAtMy4zOC0uOTRjLTIuMzUgMC0zLjc0IDEuMjUtMy43NCAzLjMzczEuNjMgMi44OSAyLjkzIDMuNTRjLjk1LjQ3IDEuODEuODcgMS44MSAxLjY0YTEuMjUgMS4yNSAwIDAgMS0xLjUgMS4xIDUuNzUgNS43NSAwIDAgMS0yLjU2LS43N2wtLjk0IDJhNy4xNyA3LjE3IDAgMCAwIDMuNyAxYzIuNDEgMCAzLjg2LTEuMzQgMy44Ni0zLjU4cy0xLjYzLTIuODYtMi45NC0zLjQ3Yy0uODktLjQxLTEuNjItLjc5LTEuNjItMS40OHYuMDJ6bTExNy4zMiA2LjMydi0yLjI2aDMuMzN2LTJoLTMuMzN2LTJoMy42OHYtMmgtNi4xdjguNDVhMi4xIDIuMSAwIDAgMCAuNTIgMS4zNyAxLjkgMS45IDAgMCAwIDEuNDIuNTNjMS44NyAwIDMuOTItLjA2IDQuMi0uMDd2LTJoLTMuNjh6bS01LjU1LTEuOTRhMy42OSAzLjY5IDAgMCAwIDEuMzMtM2MwLTIuNDgtMi4xMi0zLjM3LTQuMS0zLjM3aC0zLjQxdjEwLjNoMi41OHYtMy4xMmgxLjI2YTcuODIgNy44MiAwIDAgMSAxLjE1IDMuMTRoMi44YTExLjQ1IDExLjQ1IDAgMCAwLTEuNTktNHptLTEuMzktMi42NWExLjI5IDEuMjkgMCAwIDEtMS40NiAxLjUzIDYuMzIgNi4zMiAwIDAgMS0uNzMgMHYtMy4yOWguNzZjMS4xOSAwIDEuNDMuNjggMS40MyAxLjc4di0uMDJ6bS02LjcgMi45NHYtNi42NWgtMi42OHY2Ljg3YzAgMS4wNi0uMDYgMS43LTEuMjQgMS43cy0xLjMyLS41My0xLjMyLTEuNzJ2LTYuODVoLTIuNjR2N2MwIDIuNDYgMS4xOSAzLjU2IDMuODcgMy41NnM0LTEuMjUgNC0zLjkzem0tMTEuNC00LjU0aDJ2LTIuMTFoLTd2Mi4xMWgyLjMydjguMjFoMi42N3YtOC4yMWguMDF6bS03Ljg1IDguMmgyLjc2bC0yLjQ3LTEwLjMyaC00bC0yLjUyIDEwLjMyaDIuNjJsLjM4LTEuNjZoMi44N2wuMzcgMS42NHptLS42Ny0zLjU5aC0yLjI3bDEuMDctNC40OGguMTFsMS4wOCA0LjQ2em0tMTAuMDggMy41OWgzdi0xMS41NWgtMi40M2wuMSA4LjA2LTMuNzktOC4wNmgtM3YxMS41NmgyLjQ0di03LjgzeiIgZmlsbD0iIzczNzM3MyIvPjwvc3ZnPg==">
 </image>
 </svg>
 </a>
 <p class=app-footer__copyright>© 2022 Springer Nature Switzerland AG. Part of <a target=_blank rel=noopener href=https://www.springernature.com/>Springer Nature</a>.</p>
 
 </div>
 </footer>
 </div>
 
 
 
 <svg class="u-hide hide">
 <symbol id=global-icon-chevron-right viewBox="0 0 10 10" xmlns=http://www.w3.org/2000/svg>
 <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill=currentColor fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path>
 </symbol>
 <symbol id=global-icon-download viewBox="0 0 16 16">
 <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-email viewBox="0 0 18 18">
 <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-institution viewBox="0 0 18 18">
 <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-search viewBox="0 0 22 22">
 <path fill-rule=evenodd d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"></path>
 </symbol>
 <symbol id=icon-info viewBox="0 0 18 18">
 <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-success viewBox="0 0 18 18">
 <path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-chevron-down viewBox="0 0 16 16">
 <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 1)"></path>
 </symbol>
 <symbol id=icon-warning viewBox="0 0 18 18">
 <path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-plus viewBox="0 0 16 16">
 <path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-minus viewBox="0 0 16 16">
 <path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-error viewBox="0 0 18 18">
 <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill=currentColor fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-springer-arrow-left>
 <path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path>
 </symbol>
 <symbol id=icon-springer-arrow-right>
 <path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path>
 </symbol>
 <symbol id=icon-arrow-up viewBox="0 0 16 16">
 <path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-tick viewBox="0 0 24 24">
 <path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z"></path>
 </symbol>
 <symbol id=icon-expand-image viewBox="0 0 18 18">
 <path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill=currentColor fill-rule=evenodd></path>
 </symbol>
 </svg>
